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Abstract  
Based on their pharmacological properties, psychoactive drugs are supposed to take control 
of the natural reward system to finally drive compulsory drug seeking and consumption. 
However, psychoactive drugs are not used in an arbitrary way as pure pharmacological 
reinforcement would suggest, but rather in a highly specific manner depending on non-
pharmacological factors. While pharmacological effects of psychoactive drugs are well 
studied, neurobiological mechanisms of non-pharmacological factors are less well 
understood. Here we review the emerging neurobiological mechanisms beyond 
pharmacological reinforcement which determine drug effects and use frequency. Important 
progress was made on the understanding of how the character of an environment and social 
stress determine drug self-administration. This is expanded by new evidence on how 
behavioral alternatives and opportunities for drug instrumentalization generate different 
patterns of drug choice. Emerging evidence suggests that the neurobiology of non-
pharmacological factors strongly determines pharmacological and behavioral drug action 
and may, thus, give rise for an expanded system’s approach of psychoactive drug use and 
addiction.   
Abbreviations 
Ach – acetylcholine; ASM - acid sphingomyelinase; BDNF – brain derived neurotrophic 
factor; BNST – bed nucleus of stria terminalis; CB – cannabinoid; CRF - corticotrophic 
releasing factor; CRFBP - corticotrophic releasing factor binding protein; CRFR- 
corticotrophic releasing factor receptor; DA – dopamine; DH - dorsal hippocampus; 5-HT – 
5-hydroxytryptamine/ serotonin; fMRI - functional magnetic resonance imaging; GABA – -
amino-butyric acid; GHB – -hydroxybutyrate; HPA - hypothalamic–pituitary–adrenal; LPS – 
lipopolysaccharide; LSD - lysergic acid diethylamide; MDMA – 
methylenedioxymethamphetamine/ ecstasy; MIA - maternal immune activation; NAc - 
nucleus accumbens; NA – noradrenaline; nAChR - nicotinergic acetylcholine receptor; PFC 
- prefrontal cortex; USVs - ultrasonic vocalizations; PTSD - posttraumatic stress disorder; 
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SNP - single nucleotide polymorphism; SUD - substance use disorder; tgASM - acid 
sphingomyelinase over-expressing; THC - 9-tetrahydrocannabinol; VTA - ventral tegmental 
area; WT – wild type 
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1. Introduction 
Drug addiction is a common psychiatric disorder. It carries a burden for individuals and 
for society (Nutt et al., 2007; Rehm et al., 2009; Degenhardt et al., 2009). Despite decades 
of intensive research, there is still no widely effective treatment available which may cure the 
symptoms of addiction or target its origin in a way to re-establish a controlled drug use or 
complete abstinence from drugs. To understand how drug addiction develops is still a major 
challenge for behavioral neuroscience and psychiatry. Early views on addiction development 
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are centered around the understanding of psychoactive drugs as pharmacological reinforcer 
(Wise, 1994, 2002; Koob, 1992; Koob et al., 1998) and addiction as an aberrant learning 
mediated by the reinforcement- (Di Chiara 1995) and stress system (Koob and LeMoal, 
1997; Koob et al., 2004; Koob, 2009). More recent views have acknowledged a role of 
various memory systems in the establishment of drug use and addiction (White, 1996; 
Nestler, 2002; Kelley, 2004; Hyman et al., 2006; Robbins et al., 2008; Müller and Schumann, 
2011a, 2011b; Müller, 2013) and of impulse control (Ahmed et al., 2002; Vanderschuren and 
Everitt, 2004; Belin et al., 2008; Everitt et al., 2008; Hopf and Lesscher, 2014). Although 
there have been attempts to promote one explanatory model over others (Koob and Volkow, 
2016; Volkow et al., 2016), there is currently no generally agreed model that captures the 
whole phenomenon in humans and its underlying socioeconomic, environmental and 
neurobiological mechanisms (Hall et al., 2015; Badiani et al., 2018; Müller, 2018). 
While the pharmacological action of widely used psychoactive drugs is increasingly 
understood (e.g. McBride et al., 1999; Spanagel, 2009), it does not allow yet to develop a 
full systems view of how drugs work. This has to consider  organisms with a spectrum of 
physical and psychological properties. Individuals live in rather complex environments with 
various niches (Laland et al., 2000; Badiani, 2013), multiple behavioral demands (Müller and 
Schumann, 2011a, 2011b) and opportunities (Ahmed, 2010) and generally in a social context 
(Burke and Miczek, 2014). Here we review some of the non-pharmacological determinants 
of psychoactive drug action, their possible contribution to addiction development and related 
neurobiological mechanisms. Thereby, we focus on recent developments that particularly 
contributed to broaden our understanding. They are related by the fact that they modulate 
drug use and addiction, but emerged from largely independent lines of research.     
2.1.  The reinforcing effects of addictive drugs: it's all about location  
As noted by Kendler and colleagues in a seminal paper (2003) “a central question in the 
etiology of drug abuse is the extent to which the risk factors for the use or misuse of a 
particular class of psychoactive substances are specific to that class or are non-specific in 
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that they predispose the individual to the use or misuse of a wide range of such compounds”.  
Studies conducted in adult male twins showed that genetic factors do not contribute 
significantly to the substance-specificity of drug abuse.  In contrast, environmental influences 
unique to the person appear to be the sole determinants of the substance-specificity of drug 
abuse (Kendler et al. 2003).  Interestingly, the relative contribution of genetic and 
environmental influences seems to be very different for cocaine versus heroin abuse. 
Indeed, Kendler and colleagues (2003) found that genetic factors account for two thirds of 
variance in the vulnerability to cocaine abuse, versus only one fifth for heroin abuse. These 
findings not only unveil a fundamental dissociation in the risk factors for cocaine versus 
heroin addiction, but also run contrary to widespread assumptions about the nature of 
environmental influences on drug abuse and drug preference. The role of context is usually 
conceptualized in the light of substantially unitary theories of drug addiction (Badiani et al. 
2011).  Adverse life experiences, for example, are thought to facilitate drug abuse in general 
(Moeller 2012; Sinha 2008). The animal models that have been developed to investigate this 
interaction reflect this assumption (Caprioli et al. 2007a).  Similarly, drug related cues are 
thought to trigger drug seeking in a more or less substance-specific manner, but through 
largely overlapping mechanisms based on associative learning (Moeller 2012; Jasinska et 
al. 2014). However, as discussed in the next sections, evidence from animal and human 
studies is beginning to shed some light on the substance-specificity of at least some type of 
drug–environment interactions. 
2.1.1. Cocaine versus heroin preference as a function of setting in the rat 
Intravenous self-administration experiments in the rat have shown that the psychological 
setting has a powerful influence on the preference for opiates versus psychostimulants. In 
these experiments some rats were housed in the self-administration chambers (Resident 
rats).  Other rats were transferred to the self-administration chambers only for the testing 
sessions (Non Resident rats). Thus, although the test environment, i.e., the self-
administration chamber, was physically identical, Residents rats were tested ‘at home’ 
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whereas Non Resident rats were tested ‘outside the home’.  Resident rats self-administered 
more heroin than Non Resident rats (Caprioli et al. 2008) whereas Non Resident rats self-
administered more cocaine and amphetamine than Resident rats (Caprioli et al. 2007b, 
2008).  Resident rats were also more motivated to work for heroin than Non Resident rats. 
This was indicated by progressive ratio experiments in which the number of lever presses 
required to obtain a single drug infusion was progressively increased either within session 
(Caprioli et al. 2008) or over subsequent sessions (Caprioli et al. 2009). The opposite was 
observed for cocaine (Caprioli et al. 2007, 2009). Most important, when the rats were given 
the opportunity to choose between heroin and cocaine within the same session for several 
consecutive sessions (Caprioli et al. 2009), the Resident rats tended to prefer heroin, 
whereas the Non Resident rats tended to prefer cocaine, with a five-fold shift in the 
heroin/cocaine preference ratio (Fig. 1).   
2.1.2. Setting preferences for cocaine versus heroin use as a function of drug in 
humans with substance use disorder 
The findings in rats were translated to humans in experiments in which individuals with 
heroin and cocaine use disorder were asked to report on the preferred setting of use for the 
two drugs. They indicated opposite preferences: heroin was mostly used at home whereas 
cocaine was mostly used outside the home (Caprioli et al., 2009; Badiani and Spagnolo, 
2013). Similar results were observed for both solitary and social use and for all routes of 
drug administration, indicating that these preferences were not a mere consequence of 
social or practical considerations (Fig. 2). The findings from the rat studies summarized in 
the previous section (Tab. 1) indicate that the results obtained in humans were not a trivial 
consequence of the addicts’ conscious decision to take a sedative drug in a place where one 
can relax, and an activating drug where one can move around. Instead, they reflected 
fundamental and substance-specific influences of setting on the response to drugs. 
2.1.3. Why do human and rats prefer using cocaine and heroin in different context? 
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To account for the ability of the setting to influence in opposite ways the reinforcing 
effects of heroin and cocaine, it has been proposed that the overall rewarding effects of 
addictive drugs are the result of a complex interaction between their central and peripheral 
effects and the setting of drug use (Badiani, 2013). In the presence of a mismatch between 
exteroceptive information (setting) and interoceptive information generated by central and 
peripheral drug actions, the affective valence of drug experience would be more negative 
than in conditions in which there was no such a mismatch. A specific instance of this theory 
is represented by the arousal state mismatch hypothesis.  By activating noradrenergic 
transmission both centrally and peripherally, via blockade of norepinephrine reuptake; 
Billman, 1995; Sofuoglu and Sewell, 2009), cocaine produces a state of arousal which 
usually occurs when an individual is exposed to exciting, potentially dangerous contexts. 
Such a state of arousal would be at odds with presumably quiet and safe domestic settings, 
hence a ‘mismatch’, but not with exciting non domestic settings. In contrast to the 
sympathomimetic effects of cocaine, heroin depresses the central nervous system and 
produces parasympathomimetic-like effects such as bradycardia (Haddad and Lasala, 1987; 
Thornhill et al., 1989; Nilsson et al., 2016). When heroin is taken at outside the home, there 
is a mismatch between exteroceptive information requiring alertness and vigilance and 
interoceptive information signaling reduced arousal and relaxation. In summary, the setting 
of drug use provides “an ecological backdrop” against which the central and peripheral 
effects of drugs are appraised. When a mismatch between exteroceptive and interoceptive 
information is detected, the rewarding effect of the drug is thwarted (Badiani, 2013). The 
sedative effects of heroin would be at odds with exciting, potentially dangerous non-home 
settings, resulting in another type of mismatch, but not in a domestic setting.   
Preliminary support for this hypothesis comes from experiments with drugs that, like 
opiates, produce sedation or that, like psychostimulants, produce arousal (Fig. 3).  Indeed, 
we found that rats self-administer more alcohol, which by acting as an allosteric agonist at 
-amino-butyric acid (GABA)A receptors produces sedation and anxiolysis, at home than 
outside the home (Testa et al., 2011). This is consistent with findings from an epidemiological 
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study in heavy drinkers (Nyaronga et al., 2009). On the other hand, ketamine, which shares 
with psychostimulants the ability to activate adrenergic transmission by acting as an agonist 
at α - and β -adrenergic receptors (Bevan et al., 1997), is preferentially self-administered 
outside the home, both by humans and by rats (De Luca et al., 2011, 2012). 
Two main predictions originate from the hypothesis highlighted above. The first 
prediction is that the positive valence of the affective response to cocaine would be greater 
outside the home than at home, whereas the opposite would occur for heroin.  The second 
prediction is that in response to heroin and cocaine the activity levels of brain areas 
implicated in processing drug reward, including the prefrontal cortex (PFC) and the striatum 
(Volkow et al., 1999; Cox et al., 2009) would be influenced in opposite manner by the setting. 
In the following sections we will examine the findings of two recent studies aimed at 
investigating these two predictions. 
2.1.4. The affective response to cocaine and heroin is influenced in opposite 
directions by the environmental context both in humans and in rats 
We used ultrasonic vocalizations (USVs) in the range of 50 kHz to investigate the 
affective response to heroin and cocaine in the rat. It has been reported that rats emit 50-
kHz USVs when exposed to natural rewarding stimuli (White et al. 1990; Knutson et al. 1998; 
Panksepp and Burgdorf 2000; Burgdorf et al. 2000) as well as to addictive drugs (Knutson 
et al. 1999; Maier et al. 2010). Consistent with the arousal state mismatch hypothesis, we 
found that at home, rats emit more 50-kHz USVs when self-administering heroine than when 
self-administering cocaine (Fig. 4). Outside the home, the rats emit more 50-kHz USVs in 
response to cocaine than to heroine (Avvisati et al., 2016). 
These findings were extended to humans in a recent translational study by De Pirro and 
colleagues (2018), who used a novel test of emotional states to investigate the affective 
response to heroin and cocaine in humans with substance use disorder (SUD) who co-
abused the two drugs. The affective state produced by heroin was appraised as more 
pleasant when the drug was used at home than when it was when used outside the home, 
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whereas the affective state produced by cocaine was rated as more pleasant when the drug 
was used outside the home then when used at home. More specifically, the results confirmed 
that the shift in the affective valence of heroin occurred in combination with its sedative 
effects, whereas the shift in the affective valence of cocaine occurred in association with its 
arousing effects. 
2.1.5. Drug-setting interactions in brain reward regions 
A series of studies in which rats received non-contingent drug administrations have 
shown that drug-induced expression of immediate early genes, used as an index of neuronal 
activation, in the PFC and in the striatal complex is powerfully modulated by environmental 
context (Badiani et al., 1998, 1999; Uslaner et al. 2001a, 2001b; Ferguson et al., 2004; Hope 
et al., 2006; Paolone et al., 2007; Celentano et al., 2009). Most important, these studies 
show that the pattern of changes as a function of context is very different in the case of 
opiates, morphine or heroin, versus psychostimulants, such as cocaine and amphetamine. 
Very recently we conducted a study to begin exploring the neural basis of drug-
setting interactions in humans with SUD, using an emotional imagery task and 
functional Magnetic Resonance Imaging (fMRI). We hypothesized a double 
dissociation, as a function of drug and setting, in the activity levels of the PFC and 
the striatum. Indeed, the results confirmed our prediction. Interestingly, the portion 
of the striatum involved in the interaction was the dorsal caudate and not the ventral 
striatum (Volkow et al., 2006; Wong et al., 2006; Boileau et al., 2007; Cox et al., 
2017). Furthermore, we found the same double dissociation bilaterally in the 
cerebellum, which has been recently implicated in drug addiction (for a review see: 
Miquel et al., 2009; Moulton et al., 2014). Indeed, the traditional view of the 
cerebellum as a primarily motor structure has undergone a radical revision in the 
past decade based on evidence indicating its role in the computation of emotional 
perception, the evaluation of emotional contexts, and the regulation of emotional 
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states in relation to context-dependent tasks (Schmahmann, 1996, 2004; 
Schmahmann and Sherman, 1998; Scheuerecker et al., 2007; Stoodley, 2012; 
Buckner, 2013; Adamaszek et al., 2014, 2017; Van Overwalle et al., 2015). In 
summary, those findings suggest that the fronto-striatal-cerebellar network is 
implicated in the contextualization of drug-induced affect.   
2.1.6. Drug setting interaction and vulnerability to relapse 
The propensity to relapse into drug seeking after a period of abstinence is one of the defining 
characteristics of substance use disorders (American Psychiatric Association 2013).  
Relapse can be precipitated by a variety of triggers including exposure to small amounts of 
the drug, such as a snort of cocaine (Jaffe et al. 1989).  Using an animal model of drug-
induced relapse (Shaham et al., 2003), Leri and Stewart (2001) have shown that drug 
‘priming’ can be substance-specific.  Rats that had been trained to self-administer both 
heroin and cocaine relapse in fact into heroin-seeking when primed with the heroin and into 
cocaine-seeking when primed with cocaine. We have shown that even the priming effects of 
cocaine versus heroin are influenced by the setting in opposite manner (Montanari et al. 
2015). Indeed, rats that had been trained to self-administer both heroin and cocaine, and 
were than given, after a period of abstinence, priming injections of heroin or cocaine, 
relapsed into heroin seeking, but not cocaine seeking at home.  Outside the home, they 
relapsed into cocaine seeking, but not heroin seeking (Fig. 5). 
2.1.7. It is all about locations 
The findings discussed in the previous sections suggest that the effects of opiates and 
psychostimulants in both rats and humans (Tab. 1) depend on dissociable psychological and 
neural substrates. They also indicate that therapeutic approaches to addiction should take 
the peculiarities of different drug classes and the settings of drug use into account. This 
challenges standard unitary models of drug reward and drug addiction that focus on shared 
substrates of drug action and on shared neuroadaptations to drug exposure (for a discussion 
of this issue see also: Badiani et al. 2011, 2018; Badiani 2013, Badiani 2014). Furthermore, 
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by emphasizing the distinctive effects of different classes of drugs and the importance of the 
context of drug use, these findings have potential clinical implications.  For example, it would 
be important to verify if the setting can influence in a substance-specific manner the initial 
phases of drug use in humans, as seen in rats (Caprioli et al. 2007b, 2008).  Another 
important aim for future research would be to assess the influence of the setting on the 
propensity of polydrug users to relapse into using one drug instead of others, as shown in 
rats (Montanari et al. 2015). This might have potential therapeutic implications, especially for 
the prevention of relapse in real world settings, e.g. via Ecological Momentary Interventions 
(Epstein et al., 2009). 
2.2. Escalation of drug self-administration as a result of experiences with social stress 
Experience with social stress determines how readily an individual begins to seek and 
take drugs, escalates drug intake to a compulsive level, and relapses after abstinence 
periods (Sinha 2001; Sinha 2008). The host of factors determining the initiation, escalation 
and relapse of drug seeking and taking comprises distal genetic predispositions and proximal 
environmental and social triggers as well as pharmacological variables that interact with 
each other. Experience with several types of stress, including novelty stress causes 
individuals to initiate cocaine and other stimulant use earlier (Piazza and LeMoal 1996). 
Stressful experiences prompt more rapid transitions to high-dose and binge patterns of 
cocaine use (Kreek et al. 2005). Self-report studies document stronger cocaine cravings 
during stress imagery (Sinha et al. 1999). By contrast the link between stress and alcohol 
consumption is more complex and limited to stress-susceptible individuals. For the last 
decades preclinical laboratory models of stress have led to many inconsistent findings with 
regard to subsequent alcohol preference and intake (as reviewed by Pohorecky 1981, 1990; 
Becker et al. 2011; but see Noori et al. 2014). Here, the focus is on the understudied 
mechanisms via which social stress promotes alcohol and psychomotor stimulant self-
administration in preclinical animal models using ethologically and experimentally validated 
methods. Both the intensely rewarding effects of cocaine and other drugs of abuse as well 
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as the ostensibly aversive effects of social stress rely on the activation of the 
mesocorticolimbic dopamine (DA) systems which, in turn, is modulated by neuropeptides. 
Ever since the discovery of their amino acid sequence (Vale et al. 1981), extra-hypothalamic 
neuropeptides such as corticotrophic releasing factor (CRF; encoded by the CRH gene) 
have received considerable attention because - not the least of which - of their significant 
role in the neural network that mediates drug abuse initiation, escalation and relapse in 
preclinical models (Bernardi et al. 2017; Sarnyai et al. 2001). 
Early on we observed that accumulating experiences with social defeat stress in 
recombinant inbred mice induces analgesia as a result of activation of endogenous opioid 
peptides that act on mu- and delta receptors (Miczek et al. 1982). More recently, our focus 
has been on brief episodes of social defeat stress and the ensuing neuroplastic changes in 
DA, brain derived neurotrophic factor (BDNF)- and CRF signaling that ultimately led to 
persistently escalated cocaine self-administration and alcohol consumption in rodent models 
(Miczek et al. 2008; Miczek and Mutschler 1996; Norman et al. 2015). Initially, we sought to 
investigate under which conditions brief episodes of mild or moderate social defeat stress 
escalate intravenous cocaine self-administration in adult or adolescent male and female rats 
and mice. By targeting the CRF/glucocorticoid system, we explored whether the effects of 
periodic social defeat stress can be prevented by pharmacological protection of CRF 
receptor subtypes or, alternatively, can also be reversed after an abstinence phase. 
2.2.1. Intermittent vs. continuous social stress and IV cocaine self-administration   
The activational effects of mild to moderate stress contrast with the debilitating, 
impairing effects of uncontrollable more intense stress. This inverted U-shaped relationship 
applies also to social stress (Miczek et al. 2008; Sapolsky 2015). A key variable is the 
intermittency of social stress. After Long-Evans rats are exposed  to intermittent episodes of 
social defeat stress in four brief confrontations with an aggressive resident rat, they acquire 
subsequently cocaine self-administration more quickly, are often more resistant to 
progressively higher work demands for obtaining cocaine, and self-administer cocaine at 
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higher rates during 24-h unlimited access (Fig. 6; Boyson et al. 2014; Holly et al. 2012; 
Leonard et al. 2017; Miczek et al. 2011; Miczek and Mutschler 1996; Shimamoto et al. 2015; 
Tidey and Miczek 1997). Ongoing studies in mice provide further evidence of escalated 
cocaine self-administration several weeks after experiencing ten intermittent episodes of 
social defeat stress (Yap et al. 2015; Arena et al. in progress). By contrast, prolonged 
exposure to social subordination stress in rats induces divergent effects, namely reduced 
cocaine self-administration (Miczek et al. 2011; Shimamoto et al. 2015). This latter effect is 
part of a depressive-like profile that is often referred to as anhedonia (Berton et al. 2006; 
Papp et al. 1991; Rygula et al. 2005). These initial studies emphasize how important timing 
of social stress episodes is in the production of consistent and robust changes in alcohol and 
cocaine intake. 
2.2.2. Social stress in female vs. male rodents and IV cocaine self-administration 
Women are more likely to initiate cocaine use at a younger age (Chen and Kandel 2002), 
transition from first use to dependence at a faster rate (McCance-Katz et al. 1999), consume 
more readily cocaine in a “binge”-like pattern (O’Brien and Anthony 2005), self-administer 
cocaine more often (Chen and Kandel 2002), and are more likely to relapse (Ignjatova and 
Raleva 2009) than men.  It has been challenging to develop a preclinical model of social 
stress in females, although recently valiant attempts have been proposed to artificially induce 
a male to attack a female mouse (Harris et al. 2018; Takahashi et al. 2017). With a focus on 
female-female rivalry, post-partum female rodents will threaten and attack reliably an intruder 
female (Haney and Miczek 1989). Under these conditions, the socially stressed intruder 
female has revealed much larger cocaine effects than males that were subjected to the same 
schedule of four social defeat episodes over the course of 10 days (Fig. 7; Holly et al. 2012). 
Specifically, female rats displayed larger behavioral sensitization and more persistent 
dopamine response to a cocaine challenge ten days after the last of four defeat episodes. 
Importantly, from a translational perspective, females with a history of brief episodes of social 
defeat stress self-administered significantly more cocaine during a 24-h unlimited access 
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“binge.” These data support the hypothesis that females with a history of brief episodes of 
social stress show a larger and more persistent behavioral and neural cross-sensitization as 
well as escalated cocaine self-administration than males. Some correlational evidence 
points to estrogens as contributors to the mechanistic source for the interaction between the 
experience with brief episodes of social defeat stress and subsequent cocaine self-
administration (Becker and Koob 2016). 
2.2.3. Social stress in adolescence and adult cocaine self-administration in a rodent 
model 
Consistent evidence points to experiences with social stress not only in adulthood, but 
especially in adolescence as significant promotors of increased drug use (Hoffmann et al. 
2000; Nelson et al. 1995; Tharp-Taylor et al. 2009). It has proven difficult to capture the 
essential features of social stress in adolescent rodent models for the purpose of 
investigating the mediating neural mechanisms that promote drug self-administration later in 
life.  In a recent series of experiments, male resident rats were selected for their propensity 
to attack reliably adolescent rats during four brief encounters (Burke et al. 2016; Burke and 
Miczek 2015). Four brief episodes of social defeat stress during adolescence (i.e. P35-44) 
were sufficient to significantly escalate cocaine self-administration when the drug was 
available during progressively higher behavioral demands (i.e. progressive ratio schedule of 
cocaine reinforcement) and during a 24-h continuous access “binge” (i.e. fixed ratio schedule 
of cocaine reinforcement). These results extend those with adult rats that were subjected to 
the same intermittent social defeat protocol (Covington and Miczek 2005). Future work 
needs to delineate a critical period during which brief episodes of social defeat stress must 
occur in order to induce neuroadaptations that lead to escalated cocaine self-administration 
40 days after the last stress episode. Altogether, these data show that brief episodes of 
social defeat stress early in life are sufficient to induce large increases in cocaine binges 
later in life. 
2.2.4. Species-generality of social defeat stress: focus on rat and mouse  
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While most preclinical research focuses on mice, rats and non-human primates, 
considerable insight into the neural mechanisms of social stress can be gained by studying 
animal species with divergent social organizations. When individuals disperse, mark and 
defend their territory such as, for example, tree shrews or certain species of mice and 
hamsters (Berdoy and Drickamer 2007; Fuchs and Flügge 2002; Greenberg et al. 2015; 
Huhman 2006; Kollack-Walker et al. 1997), species-specific coping mechanisms can be 
identified. By contrast, so-called social species such as voles, rats and non-human primates 
cope with an elaborate repertoire of submissive and defensive displays that enable cohesive 
social groups (Koolhaas et al. 2011; Von Holst 1998). In laboratory research precise control 
of the timing, intensity and frequency of social confrontations is implemented in order to 
define the necessary and sufficient conditions of social stress in mice, rats and non-human 
primates that result in escalated alcohol and drug self-administration.  
Parametric studies have identified robust and persistent effects of brief episodes of 
social defeat stress in mice and rats. For example, four brief episodes, separated by three 
days, emerged as sufficient to engender augmented motor activation in rats upon a 
challenge with a low dose of amphetamine or cocaine (Covington and and Miczek 2001). 
Similar behavioral sensitization was evident in outbred Swiss-derived and inbred C57BL/6J 
mice after ten brief confrontations with an aggressive resident opponent, each separated 
from the next by one day (Han et al. 2017; Yap et al. 2015). Ten days after the last social 
confrontation rats and mice began to self-administer cocaine intravenously. Two to three 
weeks later, they were subjected to a probe during which they were reinforced for their 
responding by progressively higher demands (i.e. progressive ratio schedule of cocaine 
reinforcement). Social stress-experienced rats were subjected to a second probe, during 
which they had unlimited access to cocaine for 24 h (“binge”). Both mice and rats with a 
history of intermittent episodes of social defeat stress self-administered cocaine at higher 
rates. Specifically, mice and rats acquired cocaine self-administration at higher rates 
(Leonard et al. 2017; Tidey and Miczek 1996; Arena et al. unpublished data), increased 
cocaine self-administration at low to intermediate unit doses of cocaine during limited access 
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sessions (Miczek and Mutschler 1996; Yap and Miczek 2007; Arena et al. unpublished) and 
reinstated cocaine self-administration after several weeks of extinction or abstinence (Han 
et al. 2017). In addition, social stress-experienced rats achieved higher break points than 
controls when cocaine reinforcement was scheduled after progressively higher behavioral 
demands (Burke and Miczek 2015; Covington and Miczek 2005). From a translational 
perspective, the most important and robust effect of prior experience with repeated episodes 
of social defeat stress is the subsequent escalation of cocaine self-administration during 
unlimited access (“binge”) in rats, even weeks after the last stress episode (Boyson et al. 
2014; Burke and Miczek 2015; Covington et al. 2005; Covington and Miczek 2001; Holly et 
al. 2012; Quadros and Miczek 2009; Leonard et al., unpublished data). Mice self-administer 
cocaine in a “burst-and-pause” pattern, whereas most rats self-administer with metronome-
like regularity, and this pattern is maintained even after social defeat stress (but see: 
Tornatzky and Miczek 2000). Even though variations in the social stress parameters and in 
the specific species of the stressed individual produce important differences in coping with 
stress, the escalation of cocaine seeking and taking is consistently seen after experiences 
with intermittent episodes of social stress. 
2.2.5. Reinstatement of cocaine seeking and social stress 
A particularly intriguing consequence of brief episodes of social defeat stress is their 
triggering long-lasting neuroadaptations. The behavioral and pharmacological evidence for 
these persistent adaptations is revealed several weeks after the experience of the last 
episode of social defeat stress. At this point in the protocol, mice have acquired and 
maintained cocaine self-administration, undergone two weeks of abstinence and then are 
exposed to the contextual cues associated with previous cocaine self-administration. When 
stress-experienced mice are exposed to the operandum that was previously reinforced with 
cocaine infusions, they increase their rate of responding. This increase in reinstated cocaine-
seeking points to the long-lasting effects of brief social stress experiences (Han et al. 
unpublished data). 
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2.2.6. Intensity of social stress and alcohol consumption  
The cross-sensitization between social stress episodes and drugs is readily 
demonstrated with psychomotor stimulants, but emerges under more limited conditions also 
with alcohol. An important issue in comparing the effects of social stress in males and 
females is how accurately the stress experiences are matched in both sexes. One strategy 
is to focus on male-male vs. female-female rivalries in order to engender sex-specific coping 
behavior (Newman et al., in preparation). Another strategy relies on a consistent stimulus 
animal that delivers the social stress either to males or females, usually as a result of artificial 
stimulation (Takahashi et al. 2017). The intensity of social stress and its frequency per unit 
time are key parameters that determine how subsequent alcohol consumption is affected 
(Fig. 8; Hwa et al. 2016; Norman et al. 2015). Brief episodes of social defeat stress in graded 
intensities result in systematically escalated alcohol consumption. In male mice, ten days 
after having experienced daily episodes of social defeat stress while exposed to 30 attack 
bites engendered consumption of maximally 20-25 g/kg ethanol (20% w/v) every day for at 
least 4-8 weeks. The daily consumption of alcohol escalates even further to ca. 30 g/kg/day 
ethanol in female outbred or B6 mice (Hwa et al. 2011; Newman et al., in preparation). By 
contrast, when social stress is inescapable, more intense, longer and more frequent, it 
impairs many neurobiological functions (Sapolsky 2015), among them also cocaine self-
administration and alcohol consumption (Fig. 6; Miczek et al. 2011; Norman et al. 2015; 
Shimamoto et al. 2015; Van Erp and Miczek 2001). The ascending limb of the inverted U 
delineates the activational effects of social stress on alcohol and cocaine self-administration, 
whereas the impairing, deleterious effects of social stress characterize the descending limb 
of inverted U. The neurobiological mechanisms for the two limbs of the inverted U await 
adequate identification. 
2.2.7. Intermittent vs. continuous access to alcohol  
In addition to the escalating effects of intermittent episodes of social defeat stress, a 
further stressful intervention that potently escalates alcohol consumption is intermittent 
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access to alcohol (Hwa et al. 2011; Hwa et al. 2013; Hwa et al. 2015; Simms et al. 2008). 
Intermittent access escalates also intravenous cocaine self-administration in rats (Kawa et 
al. 2016). Intermittency emerged as a key feature of access conditions to induce a 
persistently escalated level of alcohol consumption both in mice and rats. Specifically, 24-h 
access to 20% w/v ethanol in one of two concurrently available bottles every other day led 
to persistently and preferentially increased consumption of alcohol (Hwa et al. 2011). In a 
further series of experiments, the interactive effects of two stress manipulations was 
investigated by initially exposing B6 mice to ten intermittent episodes of social defeat stress 
and subsequently providing access to alcohol on alternating days in a 2-bottle choice 
protocol for four weeks (Hwa et al. 2016; Newman et al. 2018). Both a history of intermittent 
social defeat stress and intermittent access to alcohol resulted in significant escalation of 
alcohol consumption relative to non-stressed mice with continuous access to 2-bottle choice 
of water and alcohol. When male mice experienced both stressors, they drank ca. 25 g/kg/24 
h alcohol for four weeks whereas non-stressed mice with continuous access consumed less 
than 15 g ethanol/kg per day. It will be of considerable interest to learn about the phasic and 
tonic changes in aminergic systems that are the basis for the intermittency effects of both 
social stress and alcohol access conditions. 
2.2.8. Candidate mechanisms for social stress: Corticosterone and CRF interacting 
with mesocorticolimbic dopamine 
While the actions of each stressor are based on specific neural networks (Pacak and 
Palkovits 2001), most types of social stress are characterized by increased HPA activity in 
the laboratory and in the field (Covington and Miczek 2005; Fuchs and Flügge 2002; Norman 
et al. 2015; Sapolsky 1990; Sapolsky 1992; Sgoifo et al. 1998). Engaging in offensive 
aggressive behavior or defensive-submissive behavior is accompanied by large increases 
in glucocorticoid activity as is evident in the winners and losers of an agonistic confrontation 
(Covington and Miczek 2005; Schuurman 1980; Von Holst 1969). A critical difference 
between the so-called stress hormones in winners and losers is the much faster recovery to 
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the homeostatic levels in the former relative to the latter. In brief resident-intruder 
confrontations that are limited to five minutes, it takes several hours for plasma 
corticosterone levels to return to baseline values in intruder rats (Miczek et al. 1991).  
A further important feature of the corticosterone activation during brief episodes of social 
stress is the lack of habituation during the course of repeated social confrontations with 
different opponents.  Plasma corticosterone values on the first day of social conflict in the 
intruder rat did not differ from those on the 10th day (Covington and Miczek 2005). Similarly, 
after 10 days of brief daily agonistic confrontations, intruder mice continued to secrete 
significantly elevated corticosterone (Norman et al. 2015), pointing to persistent 
hypothalamic–pituitary–adrenal (HPA) axis activation.  
An influential hypothesis links glucocorticoids to the sensitizing influence of repeated 
exposure to psychomotor stimulants or stressors, supported by data from pharmacological, 
surgical and genetic manipulations of glucocorticoids (Marinelli et al. 1997; Piazza et al. 
1991). However, it is now evident that the neural circuitry for behavioral sensitization as 
induced by repeated stress or stimulant drugs can be dissociated from the transition to 
escalated drug self-administration (Miczek et al. 2008). Pharmacological blockade of 
corticosterone synthesis or glucocorticoid receptors can block cocaine reinstatement (Piazza 
et al. 1994), diminish motivation to self-administer cocaine (Deroche-Gamonet et al. 2003). 
This can also reduce stress-escalated alcohol consumption during continuous or intermittent 
access (Newman et al. 2018). 
In addition to the activation of the HPA axis, considerable evidence points to the 
significance of extra-hypothalamic CRF as modulator of canonical amines. Substantial data 
implicate the amygdaloid complex, particularly the central and basolateral nuclei, 
intercalated cells and the projections to the bed nucleus of the stria terminalis as sites of 
expression and action for CRF and CRFR1 (Jennings et al. 2013; Silberman et al. 2013; 
Zorrilla et al. 2014). In several experimental protocols for investigating the link between 
stress and drug taking, CRF was found to increase in the amygdala in alcohol-withdrawing 
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rats (Pich et al. 1995). CRF receptor expression is also upregulated after a history of alcohol 
consumption (Sommer et al. 2008). CRF signaling in the amygdala has been implicated in 
the transition to dependence as a result of repeated cycles of access to alcohol followed by 
abstinence (Breese et al. 2005; Spanagel et al. 2014). 
CRF signaling in subregions of the ventral tegmental area (VTA) has received less 
attention than other brain regions that receive projections from the amygdala such as the 
bed nucleus of stria terminalis (BNST), lateral hypothalamus and hippocampus (Pitkänen et 
al. 2000). Yet, the interactions between CRF and DA in the VTA are critical for the motivation 
of many conditioned and unconditioned behaviors including also escalated drug seeking and 
taking (Holly and Miczek 2016; Koob and Volkow 2010; Wise 2004). It remains unresolved 
how ostensibly aversive, stressful events as well as intensely rewarding drug experiences 
result in increased DA activity in the VTA and escalated alcohol and cocaine seeking and 
taking. Electrophysiological, in vivo microdialysis and fast scan voltammetry methods 
provided correlative evidence for increased DA activity in animals that were exposed to 
social defeat, electric shock pulses or other stressors (Abercrombie et al. 1989; Anstrom et 
al. 2009; Brischoux et al. 2009; Imperato et al. 1991; Tidey and Miczek 1996). Intra-VTA 
microinfusion of a non-selective CRF antagonist such as alpha-helical CRF can block DA 
release that is evoked by a footshock stressor (Wang et al. 2005). CRF R1 knockdown in 
the VTA reduces stress-induced cocaine seeking in mice (Chen et al. 2014). In a binge 
model of alcohol consumption, VTA DA neurons of juvenile mice showed potentiation of 
NMDAR currents which was blocked by a CRFR1 antagonist (Sparta et al. 2013). 
The role of CRF signaling in the VTA is demonstrated in studies of social stress that led 
to the escalation of intravenous cocaine self-administration and oral alcohol consumption in 
mice and rats (Burke et al. 2016; Han et al. 2017). Intra-VTA microinfusion of a CRFR1 
antagonist significantly decreased alcohol intake in mice and rats that accessed alcohol 
intermittently or continuously in a two-bottle choice protocol (Hwa et al. 2013). The blockade 
of intake was even more pronounced when the mice had experienced social defeat stress 
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previously and consequently escalated their alcohol consumption (Hwa et al. 2016; Newman 
et al. 2018). Importantly, CRFR1 antagonist treatment was also shown to increase DA 
release in the nucleus accumbens (NAc) (Fig. 9; Hwa et al. 2016). In addition to the 
prominent role of CRFR1 in stress-escalated alcohol consumption, initial evidence has been 
collected that the intra-VTA microinjection of antagonists of CRF binding protein (CRFBP) 
and CRFR2 reduce alcohol intake in a binge model of alcohol consumption (Albrechet-Souza 
et al. 2015).  
Activation of both CRFR1 and CRFR2 in the VTA during social defeat stress is 
necessary for the induction and later expression of behavioral and neural cross-sensitization 
to cocaine and escalated cocaine self-administration in a 24-h “binge” (Boyson et al. 2014). 
Intra-VTA antagonism of CRFR1 in the posterior VTA and CRFR2 in the anterior VTA during 
each of four intermittent social defeat episodes prevented subsequent escalated cocaine 
self-administration in a 24-h binge and later, after forced abstinence, cocaine seeking in a 
reinstatement test (Fig. 10; Holly et al. 2016; Leonard et al. 2017). These findings point to 
CRF in the VTA as a critical signal during the social stress episode that engenders not only 
a phasic response, but also induces a persistent elevation in CRF tone (Holly et al. 2016). 
We hypothesize that the CRF signal is critical for a subpopulation DA VTA cells that 
ultimately result in escalated motivation for alcohol and drug consumption. 
Interpretation of the functional significance of DA release in the mesocorticolimbic 
projections has been complicated by the observation that both intensely rewarding and 
aversive stimuli activate these cells. Moreover, the activation of DA by ostensibly aversive 
experiences such as social defeat stress escalates cocaine self-administration and alcohol 
consumption as well as dopamine release in the accumbens and prefrontal cortex.   
2.3. Drug instrumentalization in drug use and addiction  
It is generally agreed that drug addiction constitutes a maladaptive behavior (Nesse and 
Berridge, 1997). In contrast, controlled drug use was suggested to have under certain 
circumstances real and/or subjectively perceived beneficial effects on behavioral 
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performance, the achievement of life goals and well-being. This view is supported by a large 
number of interviewing studies with drug users (Lende and Smith, 2002; Lende et al., 2007; 
Hagan et al., 2009; Singh et al. 2014; Morgan et al., 2013; Wolf et al., 2014; Ross et al., 
2018). It can explain at a psychological level why psychoactive drug consumption is 
established and well maintained by the majority of humans around the globe without 
necessarily leading into a drug addiction. Human beings are not developmentally determined 
to automatically establish this behavior. Instead, they have to learn it. This learning is based 
on the capability to learn and teach it (Hopitt and Laland, 2013; Müller et al., 2012; Kline, 
2015; Müller, 2015), given the ability to modify food consumption according to non-nutritional 
needs (Rodriguez and Wrangham, 1993; Lozano, 1998; Huffman, 2003; Müller and 
Schumann, 2011a). The learning of drug use behaviors may, thus, include a de novo 
learning by trial-and-error, e.g., for newly emerging substances (Hassan et al., 2017), or a 
learning by cultural inheritance (Dean et al., 2012; Hassan et al., 2013; Hopitt and Laland, 
2013; Kline, 2015; Müller, 2015). 
Drug users, who acknowledge subjectively perceived psychological benefits of drug 
consumption (Baum-Baicker, 1985; Chick, 1999; Peele and Brodsky, 2000), are not 
consuming in an arbitrary fashion. If drug use would be solely determined by the 
pharmacological properties of a drug, one would expect the use of a particular drug emerging 
under all individual predispositions (sets) and all environmental contexts (settings) to a 
comparable degree. But this is not the case for any of the known psychoactive drugs. It was 
recently suggested that non-addicted users consume drugs because the subsequent effects 
on mental states can be used for a better performance of goal directed behaviors (Müller 
and Schumann, 2011a, 2011b; Müller, 2017). Thereby, psychoactive drugs are 
‘instrumentalized’. An instrument can be conceived as “something that helps to achieve a 
goal, which would not be achievable or require a higher workload without the use of the 
instrument” (Müller and Schumann, 2011a). Drug instrumentalization refers to a two-step 
psychological process which consists of two interlinked processes: A.) the psychoactive drug 
is sought and consumed in order to change the present mental state of a person into a 
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previously learned mental state, and B.) subsequently, the induced mental state allows for a 
better performance of another, previously established behavior (Müller and Schumann, 
2011a, 2011b; Müller, 2017).  
Mental states are the subjectively perceived working modes of the brain. They influence 
how the external and internal environments are perceived, how memory is formed and 
retrieved, and how autonomic and behavioral responses of an organism are organized. 
Mental states change frequently, and are essentially determined by the different functional 
working modes of the modulatory transmitter systems, such as, e.g., the dopaminergic-, 
serotonergic-, acetylcholinergic-, noradrenergic-, and various neuropeptidergic systems of 
the brain (Müller and Schumann, 2011a). These rather slowly acting ascending systems 
control the fast information processing in diencephalic and telencephalic target regions of 
the brain (Castren, 2005; Müller et al., 2011). Importantly, these modulatory transmitter 
systems determine the efficacy of an organism in performing previously established 
instrumental behaviors, i.e., the question of how effective an expected goal can be reached. 
Whenever an organism pursues a specific goal by performing a behavior, it can be assumed 
that there is usually one particular mental state which allows for most efficient performance. 
In real life, however, the challenge is frequently to perform a goal directed behavior when 
not being in an optimal mental state for it, e.g., driving a car when tired and inattentive. 
Humans can do this to a certain extent, but less efficiently. It requires more effort and/or a 
positive outcome is less certain. Psychoactive drugs can work as instruments in that they 
can change a present mental state into a desired mental state in a short and predictable time 
frame (Müller and Schumann, 2011a, 2011b; Müller, 2017).  
For psychoactive drugs, distinct ‘instrumentalization goals’ have been reported in 
humans, often described as drug taking motivations (Brown et al., 1980; Maloff et al., 1981; 
Brown, 1985; Cooper et al., 1995, Baum-Baicker, 1985; Chick, 1999; Heath, 2000; Peele 
and Brodsky, 2000; Lende et al., 2007). While classical reinforcement theory would assume 
that pharmacological drug action in the brain is basically the same under all those 
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circumstances, recent findings suggest that quite distinct pharmacological actions and brain 
pathways serve different drug instrumentalization goals. Here we discuss current progress 
in modeling drug instrumentalization in animals in order to investigate underlying 
neurobiological mechanisms. It should be noted that those models draw essentially from 
previously established models of drug seeking and self-administration, from context 
dependent drug choice and behavioral alternatives as described above.         
Since drug instrumentalization is more than just drug seeking and self-administration, it 
requires also a more elaborate experimental design to investigate it. If drug 
instrumentalization is demonstrated in a healthy organism, a goal directed behavior needs 
to be established. Then it has to be shown that drug self-administration really improves 
parameters of the goal directed behavior. In a non-healthy organism, first a disease model 
has to be established and proven as a valid model for a challenged (e.g. stressed) or 
pathological mental state (e.g. depression). Then it has to be shown that drug self-
administration is more pronounced in this mental state and finally reverses the state towards 
a normal (control) state (Müller, 2018). Here we discuss in how far that has been shown for 
distinct instrumentalization goals and which insights into neurobiological mechanisms this 
has yielded. For those human instrumentalization goals where no direct animal evidence is 
available, plausible mechanisms derived from pharmacological profiles of the used drugs 
are discussed. 
2.3.1. Improved social interaction 
Social interaction can be considered as a group of goal directed behaviors with innate 
rewarding effects (Matthews et al., 2005; Panksepp and Lahvis, 2007). Several psychoactive 
drugs can change the mental states in a way which facilitates social interactions with 
conspecifics. They include alcohol (Glynn et al., 1983; Bradizza et al., 1999; Kuntsche et al., 
2005), marihuana (Zvolensky et al., 2007; Bonn-Miller et al., 2007; Hartwell et al., 2012), 
cocaine (O’Malley et al., 1985; Lende, 2005), and other psychostimulants (White et al., 2006; 
Davey et al., 2007; Hassan et al., 2013), nicotine and caffeine (Eissenberg and Balster, 
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2000; Cauli and Morelli, 2005), when used in a low to medium dose range (Segal, 1985; 
Cato, 1992; Boys et al., 1999, 2001; Simons et al., 2000; Boys and Marsden, 2003; Morgan 
et al., 2013).  
In humans, alcohol reduces social inhibition, the discomfort in social situations, and 
social anxiety, and increases social approach behavior (Baum-Baicker 1985; Peele and 
Brodsky 2000; Carrigan et al. 2008; Booth and Hasking 2009). These effects occur after 
lower doses of alcohol and are mediated by multiple mechanisms in the brain (McBride et 
al. 2002; Tupala and Tiihonen 2004; Harris et al. 2008; Spanagel, 2009). An important 
mediator is the interaction of alcohol with GABAA-receptor signaling. GABA is the most 
abundant inhibitory transmitter in the brain that is crucial for conditioned suppression of 
behavior (Feldmann et al., 1997). Alcohol can enhance GABAergic activity at the GABAA-
receptor, which is directly responsible for a reduction in anxiety and behavioral disinhibition. 
Alcohol is well known to increase monoaminergic signaling in the mesolimbic system of the 
brain (Di Chiara and Imperato 1988; Spanagel, 2009; Müller and Homberg, 2015). These 
neurochemical effects were shown to reduce the reward threshold of the brain (Koob et al. 
1998), which may enhance the incentive value of social reward (Ikemoto and Panksepp 
1999; Ross and Young 2009). However, alcohol can have disruptive effects on social 
cognition most likely mediated by its action in higher cortical areas (Burnett et al. 2010; 
Uekermann and Daum 2008).  
Psychostimulant drugs, such as cocaine, amphetamine, methylphenidate, 
methamphetamine, and methylenedioxymethamphetamine (ecstasy, MDMA), are also self-
administered by humans in a social context, such as, e.g., in clubs or at parties (Britt and 
McCance-Katz 2005; White et al. 2006). Psychostimulants in a low-medium dose range 
enhance general arousal and increase attention. During periods of prolonged social 
interaction, they suppress fatigue (Fischman and Schuster 1980) and enhance aggression 
(Emley and Hutchinson 1983). Rats acutely increase their intake of cocaine following 
exposure to an aggressive dominant resident animal that they cannot avoid or escape from 
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(Miczek and Mutschler, 1996). This increase in drug intake can be interpreted, at least partly, 
as an attempt to instrumentalize some of the psychopharmacological effects of cocaine to 
better cope with some aspects of the negative psychological experience caused by an 
otherwise uncontrollable social stressor. 
All used psychostimulant drugs in this context are known to acutely enhance 
extracellular activity of DA, serotonin (5-HT), and noradrenaline (NA) in the mesolimbic 
system (Ritz and Kuhar 1989; Ritz et al. 1990) by their interaction with respective 
monoamine transporters (Johanson and Fischman 1989; Seiden et al. 1993; Green et al. 
2003; Müller et al. 2007a; Pum et al. 2007; Nutt et al., 2015). Thereby, noradrenergic effects 
may account for the sustained attention (Aston-Jones et al. 1999), 5-HT may mediate the 
anxiolytic (Schwarting et al. 1998; Ho et al. 2004; Müller et al. 2008) and aggression-
enhancing effects of these drugs (Licata et al. 1993; Quadros et al. 2010), while DA may 
enhance salience of social stimuli (Berridge and Robinson, 2003). Animal models of 
psychoactive drug self-administration with the goal to improve social interaction are, to the 
best of our knowledge, not established yet. 
Several psychoactive drugs have been reported to be used by non-addicts to facilitate social 
interactions. Exaggerated drug use for this instrumentalization goal, however, may also 
facilitate the transition to habitual drug use and addiction (e.g. Wagner and Anthony, 2002; 
Müller, 2017).  
2.3.2. Facilitation of sexual behavior 
Mating behavior is a goal directed behavior with very high rewarding properties (Patrick 
and Maggs, 2008). Sexual behavior in humans may include a behavioral complex that 
encompasses partner seeking, approach behavior, up to actual sexual intercourse. 
Numerous drugs which are instrumentalized to improve social interactions also work well for 
sexual behavior facilitation. Drugs frequently reported to be used for this purpose are alcohol, 
cannabis, amphetamines, ecstasy, and cocaine (Maier, 1926; Boys et al., 1999, 2001; Boys 
and Marsden, 2003). There is evidence for an association between  alcohol drinking, 
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drunkenness and the likelihood for sexual intercourse in humans, particular in adolescents 
and young adults (Lavikainen et al 2009; Patrick and Maggs 2008; Wells et al. 2010).  
Psychostimulant drugs may serve to improve chances for sexual behavior, but may later 
interfere with physical performance during sexual intercourse in males (Maier 1926; Waldorf 
et al. 1991). In particular the acute effects on DA in the mesolimbic system might render an 
individual more responsive to sexual cues and making a potential partner appear more 
‘attractive’ (Koob et al. 1998; Ikemoto and Panksepp, 1999). Currently, there are no animal 
models that convincingly demonstrate voluntary self-administration of psychoactive drugs to 
enhance mating behavior in conditions that resemble the human situation, i.e. with numerous 
rules installed in the shape of passive avoidance. Thus, the biological mechanisms of drug 
instrumentalization for this goal warrant investigation. 
2.3.3. Improved cognitive performance and counteracting fatigue 
Good cognitive abilities improve the outcome of complex goal directed behaviors in 
animals and humans (Arria and Wish, 2006). During wakefulness and depending on work 
load, the cognitive capacity usually declines over the activity phase of an organism. 
Pharmacological means that artificially extend periods of high cognitive capacity may, 
consequently, appear to be beneficial for the individual. While there is little evidence for 
drugs to significantly increase cognitive performance in a healthy individual with full mental 
capacity, there is evidence suggesting that mild impairments due to exhaustion, fatigue or 
mood swings can be attenuated with psychoactive drugs (Boys and Marsden, 2003; Lende 
et al., 2007; Morgan et al., 2013; Singh et al., 2014; Padwa et al., 2014; Brand et al., 2016). 
Performance pressure is often perceived as stressful and psychoactive drugs become a 
mean of “every day doping” for neuro-enhancement (Wolff and Brand, 2013; Ross et al., 
2018).  
A widely used psychoactive drug to keep people awake is caffeine, a major psychoactive 
ingredient of coffee, tea, chocolate, and soft drinks. Caffeine when consumed post-trial was 
shown to enhance the consolidation of long-term memories in humans (Borota et al., 2014). 
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During waking, the brain adenosine levels, steadily increase and may eventually trigger 
fatigue and sleep (Huston et al. 1996; Porkka-Heiskanen et al. 1997; Hong et al. 2005). 
Caffeine is an antagonist of adenosine A1- and A2A receptors, and by that way blocks action 
of accumulating adenosine (Cauli and Morelli 2005).  
Another widely used legal drug is nicotine, the active compound in tobacco (Le Foll and 
Goldberg 2006). Recent research suggests that rats can learn to increase their intake of 
nicotine before a cognitively demanding task (Nesil et al., 2015). This behavior could 
represent an attempt to instrumentalize the cognitive-enhancing effects of nicotine in 
anticipation of a cognitive effort. Nicotine is a nicotinic acetylcholine (ACh) receptor agonist 
(Markou 2008). Nicotinic ACh-receptor stimulation in the brain facilitates attention and 
subsequently learning and memory (Thiel, 2003; Sarter et al., 2005). Nicotine was shown to 
enhance attention and cognitive performance in animals (Decker et al. 1995; Hahn and 
Stolerman 2002) and in non-smoking humans (Rezvani and Levin 2001). In human smokers, 
however, cognitive abilities usually decline after smoking cessation. This can be reversed by 
nicotine (Mansvelder et al. 2006). In the brain, nicotine increases not only ACh-, but also NA 
activity (Mitchell 1993; Wonnacott 1997). Both may interact in their attention improving 
effects. Nicotinic ACh-receptor stimulation has also a direct effect on mesolimbic DA activity 
(Pontieri et al., 1996; McBride et al. 1999; Wonnacott et al. 2000; Markou, 2008). By these 
mechanisms, nicotine may enhance the incentive properties non-drug reinforcer (Harrison 
et al. 2002; Kenny and Markou 2006).  
Psychostimulant drugs have been widely used to increase cognitive performance over 
long periods of time (Grinspoon and Hedblom 2005; Davey et al. 2007; McCabe et al. 2005; 
Arria and Wish 2006; White et al. 2006; Sussman et al. 2006; Teter et al. 2006; Lende et al. 
2007). At doses that induce no or only a minor ‘high’ and little withdrawal effects, 
psychostimulants were shown to increase arousal and attention in humans for long periods 
of time (Higgins et al. 1990; Stillman et al. 1993) or attenuate sleep-deprivation induced 
deficits (Fischman and Schuster 1980). In particular the acute effects on noradrenergic 
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activity may mediate this action (Johanson and Fischman 1989; Usher et al. 1999; Seiden 
et al. 1993; Green et al. 2003). Animal models of psychoactive drug-self administration with 
the goal to improve cognitive performance are, to the best of our knowledge, not established 
yet. One possible first step to overcome these difficulties would be to test if and to what 
extent animals can instrumentalize a psychotropic drug that has no or only weak rewarding 
effects. For instance, modafinil is a psychostimulant drug that has cognitive-enhancing 
effects with weak rewarding effects in rodents when available for i.v. self-administration 
(Deroche-Gamonet et al., 2002). If animals are able to instrumentalize the cognitive-
enhancing effects of modafinil, then we should expect that they should adjust their intake as 
a function and in anticipation of the specific cognitive demands and domains of different 
tasks. In addition, we should also expect that animals may reduce or even stop their intake 
of modafinil if provided with alternative means or shortcuts to solve the same cognitive tasks. 
This research will be pivotal to demonstrate drug instrumentalization in animals, with little 
confounding by the search of drug reward. Alternatively, we could also design tasks where 
animals are offered a choice between at least two drugs of abuse while they are pursuing a 
well-identified nondrug-related goal. This will complement previous research on animals’ 
drug of choice as a function of the context (Badiani, 2013). In this situation, we should expect 
that animals would opt for the drug that produces psychopharmacological effects that are 
the most congruent, or the least incongruent, with the pursuit of that goal. If such a model 
was developed and validated, it could be used to begin to study the neural basis of drug 
instrumentalization. Of particular interest, it will be important to know how the brain 
represents drugs as instruments, as opposed to drugs as goals, and how it compares these 
representations with those of behavioral alternative means. 
Taken together, accumulating evidence supports the view that several psychoactive drugs 
are instrumentalized specifically to enhance cognitive performance. Long term regular use 
of these drugs can induce tolerance for the cognitive effects and even lead to cognitive 
deficits (Vonmoos et al., 2013; Wolff et al., 2014; Havranek et al., 2015; Müller, 2017).    
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2.3.4. Facilitated recovery and coping with psychological stress 
Modern societies require humans to perform many behaviors at high cognitive demand 
for long periods of time (Anders, 1961). Individuals have little time during their activity periods 
to efficiently recover and possibly cope with activity related psychological stress. Several 
psychoactive drugs were reported to improve recovery and to enhance stress coping (Segal, 
1985; Baum-Baicker, 1985; Peele and Brodsky, 2000; Amendt, 2003; Morgan et al., 2013). 
Humans instrumentalize alcohol (Cooper et al., 1988, 1992; Kuntsche et al., 2005), cannabis 
(Bonn-Miller et al., 2007; Zvolensky et al., 2007), cocaine (Waldorf et al., 1991; Lende, 2005), 
methamphetamine (Lende et al., 2007), barbiturates, benzodiazepines, and other sedative 
anxiolytic drugs (Boyd et al., 2009) to cope with stress (Segal, 1985; Lader, 1994; Boys et 
al., 1999, 2000; Bradizza et al., 1999; Perkins, 1999; Boys and Marsden, 2003; De Las 
Cuevas et al., 2003).   
Two of the major pharmacological effects of alcohol are the inhibition of excitatory 
glutamatergic transmission and enhancement of inhibitory GABAergic activity (Spanagel 
2009). Barbiturates and benzodiazepines also modulate the GABAA-receptor (Ito et al. 
1996), though at other binding sites than alcohol, and allosterically enhance responses to 
the inhibitory transmitter GABA (Allison and Pratt 2003). Enhanced GABAA-receptor 
signaling may reduce innate anxiety and conditioned anxiety. By their interaction with 
neocortical GABAA-receptors (Feldman et al. 1997), sedative drugs like alcohol may 
attenuate memory of aversive events (Curran, 1991).  
The interplay between stress and alcohol consumption has been extensively 
investigated in animal studies. Thereby, various types of stress have been modeled. Acute 
physiological stress was modeled by, e.g., foot shock, restraint, or forced swim stress. 
Psychological stress was induced by, e.g., overcrowding, social defeat or social isolation. 
While there is the general view that stress is associated with increased alcohol drinking, 
findings in animal models are equivocal, in that they show a reduction, no effect or an 
increase of consumption after stress. In contrast, chronic stress, e.g. by maternal separation 
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or chronic isolation, in particular when exposed at young age, tend to be more reliable 
inducer of enhanced alcohol consumption (Spanagel, 2009; Vengeliene et al., 2008; Becker 
et al., 2011). Stress typically refers to a disruption of homeostasis by external or internal 
events. While the effects of various stressors on homeostasis in the brain and on body 
function are now well characterized (de Kloet et al., 1998; Koob, 1999; Oliveira et al., 2017), 
little is known about whether alcohol self-administration would partially re-establish 
homeostasis. A stressed brain/organism is different from an unstressed one, with partially 
chronic dysregulations. Those can cause alcohol to have different effects than in a normal 
organism (Müller et al., 2017). This is something that should actually be tested when doing 
drinking studies in animals. On the other hand, alcohol can have stress effects by itself, i.e. 
chronic self-administration can induce allostasis in various functional systems of the brain 
and body periphery (Huber et al., 2017; Becker et al., 2011).   
Psychoactive drug self-administration to improve coping with stress has been observed 
in animal models for various drugs. Intravenous self-administration of heroin is increased 
when rats are exposed to mild stress in the shape of unavoidable food shocks (Shaham and 
Stewart, 1994). While the stress appears to enhance the reinforcing efficacy of the drug, it 
remained unclear whether endogenous stress markers and stress-related behavior were 
directly attenuated by the drug. Physical and emotional social defeat stress can increase 
morphine consumption in mice. Stress induces an increase of FosB immunoreactivity in 
mesocorticolimbic brain areas (Nikulina et al., 2008; Cooper et al., 2017), effects that 
resemble changes during establishment of drug addiction (Perotti et al., 2008). In how far 
morphine would reduce behavioral signs of stress and re-establish homeostasis or enhances 
drug-like effects in the brain, remains to be determined.   
A wide spread illicit psychoactive drug that is instrumentalized to cope with stress is cannabis 
(Boys et al., 1999, 2000). The main psychoactive compound of cannabis is 9-
tetrahydrocannabinol (THC; Iversen, 2000), an exogenous ligand at cannabinoid (CB) 
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receptors (Mechoulam et al., 1998). It was shown that a direct CB1 receptor activation may 
effectively enhance the extinction of aversive memories (Marsicano et al., 2002). 
Interestingly, social stress was also found to increase the self-administration of non-
sedating drugs, such as cocaine, in animals and humans. It was speculated that this might 
improve an active coping and enhance a “flight or fight” response (Müller and Schumann, 
2011a). Stress modifies the function of the mesolimbic DA system (Miczek et al., 2011; 
Kreibich et al., 2009) and its excitatory (Garcia-Keller et al., 2016) and inhibitory inputs 
(McLaughlin et al., 2003; Polter et al., 2017), in a way to cross-sensitize the system to 
subsequent psychostimulant behavioral effects and to their self-administration propensity 
(Cruz et al., 2011; Miczek et al., 2011). A single episode of social defeat stress can increase 
the mesocorticolimbic expression of the immediate early gene cFos, which is an indicator of 
neuronal activation (Miczek et al., 2011; Cooper et al., 2017). Psychostimulant drugs like 
cocaine increase cFos (Miczek et al., 2011; Schöpf et al., 2015). However, cocaine can 
counteract the social defeat stress effects on c-fos activation in distinct brain regions 
(Nikulina et al., 1998; Miczek et al., 2011). This effect may serve as an example of how 
cocaine exerts a seemingly paradoxical effect in a stressed animal that may work towards a 
re-establishment of homeostasis. However, the same studies showed that days later an 
augmented effect emerges, which suggests that potential acute instrumentalization effects 
of the drug revert after a short time and render the organism in a drug-sensitized state that 
actually facilitates addiction-development (Miczek et al., 2011). In the brain, µ- and -opioid 
receptor signaling and its activation by endogenous enkephalin and dynorphin, respectively, 
was enhanced after stress (McLaughlin et al., 2003; Nikulina et al., 2008; Polter et al., 2017). 
This effect was directly linked to stress-induced immobility and analgesia. In the VTA-NAc 
projection it may trigger the enhanced sensitivity for cocaine reward and the reinstatement 
of drug self-administration (McLaughlin et al., 2003; Miczek et al., 2011; Polter et al., 2014).  
Cocaine self-administration in order to cope with social stress was predominantly observed 
in animals with low spontaneous activity (Kabbaj et al. 2001), which suggest a dependency 
of instrumentalization efficacy on personality traits. 
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Overall, numerous psychoactive drugs are currently used to facilitate recovery and coping 
with stress by non-addicts. A chronic and escalating drug use for this instrumentalization 
goal may result in restlessness and a hyper-anxious state during withdrawal, and may result 
in compulsive drug use to overcome this state (Müller, 2017).   
2.3.5. Self-medication for psychiatric disorders and mental problems 
Mental disorders are characterized by the prolonged persistence of a mental state that 
is subjectively perceived as aversive and/or imposes significant problems and suffering for 
one’s own or others well-being. Underlying mental state changes may constitute a 
temporary, recurrent, or continuous breakdown in the homeostasis of one or more 
modulatory transmitter systems of the brain (Khantzian, 1997; Kapur, 2003; Krishnan and 
Nestler, 2008; Quednow et al., 2010; Schneider et al., 2017). It is now well documented that 
certain psychiatric disorders are associated with enhanced consumption of particular types 
of drugs and frequently with an addiction to those drugs (Robbins and Everitt, 1999). Drug 
action in those patients may be completely different from normal organisms and their benefits 
beyond simple pharmacological reinforcement. It was reported by patients that psychoactive 
drugs may provide at least a temporary relief from suffering and/or enhanced ‘functioning’ in 
everyday life (e.g. Lende et al., 2007; Padwa et al., 2014). This may also account for mental 
states that are perceived as aversive, e.g. being in a depressed mood, but not fulfilling the 
strict diagnostic criteria of a psychiatric disorder (Boys et al., 2001; Boys and Marsden, 2001; 
Boyd et al., 2006; Morgan et al., 2013). 
In humans of western societies, the most frequently used legal drug for this 
instrumentalization goal is alcohol. Numerous studies suggest that a moderate alcohol 
consumption is associated with better health, more close friendships, and more family 
support than total abstinence (Peele and Brodsky, 2000; Rodgers et al., 2000; Taylor et al., 
2005; Mondaini et al., 2009; Skogen et al., 2009). Moderate alcohol consumption was also 
linked to lower rates of stress-induced depression (Lipton, 1994; Tizabi et al., 2018), and 
reduced the risk of somatic diagnoses as well as anxiety and depression compared to 
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complete abstainers (Peele and Brodsky, 2000; Skogen et al., 2009). Evidence supports the 
view that alcohol is consumed to provide relief from negative affect (Peele and Brodsky, 
2000; Bulley et al., 2016). There is a considerable co-morbidity of the diagnoses ‘major 
depression’ and ‘alcohol addiction’ in clinical populations (Brown et al., 1995; Preuss et al., 
2002). However, this encompasses at least two different populations with possibly, distinct 
pathogenic pathways. A prevalent major depression may cause alcohol abuse and addiction. 
Alternatively, an initially established alcohol addiction may give rise to depression 
development (Room, 2000; Schuckit et al., 1997, 2006, 2007, 2013).   
Mammalian cell membranes predominantly consist of sphingolipids, cholesterol 
and (glycero)phospholipids. Sphingolipids are composed of a hydrophilic head group 
and a ceramide molecule. Ceramide consists of a D-erythro-sphingosine and a fatty 
acid of variable length with 2-36 carbon atoms in the acyl chain (Sandhoff, 2010). 
Sphingolipid molecular interactions are coordinated by membrane cholesterol 
(Brown and London, 1998; London and London, 2004; Megha et al., 2006). The 
interactions of sphingolipids with cholesterol result in an ordered membrane structure 
with stable domains in the liquid-ordered- or gel-like phase (Simons and Ikonen, 
1997; Harder and Simons, 1997; Brown and London, 1998; London and London, 
2004; Megha et al., 2006). Such domains spontaneously segregate from other 
glycerophospholipids in the membrane. Due to their membrane floating properties, 
these domains were named lipid rafts (Simons and Ikonen, 1997; Eggeling et al., 
2009). The most abundant sphingolipid, sphingomyelin, can be hydrolyzed to 
ceramide, which has the tendency to spontaneously self-associate. This process 
results in the formation of ceramide-enriched membrane microdomains that may fuse 
to large ceramide-enriched macrodomains (Veiga et al., 1999; Grassmé et al., 
2001a, 2001b, 2002a; Fanzo et al., 2003). The generation of a very high 
concentration of receptor proteins, e.g. for neurotransmitters, within small plasma 
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membrane domains seems to be prerequisite for transmembrane signaling via the 
clustered receptors (Gulbins and Kolesnick, 2003). Decreasing levels of either 
cholesterol or sphingomyelin in the brain, which was observed after learning or stress 
in animals (Huston et al. 2013; Oliveira et al., 2017), also changes the composition 
of lipid rafts. This can directly affect receptor affinity, their signaling properties, and 
subsequent internalization (Fantini et al., 2009; Ramstedt and Slotte, 2006; 
Nothdurfter et al., 2010, 2013). 
The generation of ceramide within extracellularly-oriented lipid rafts/membrane 
domains, i.e. in the outer leaflet of the plasma membrane, is mediated by the enzyme 
acid sphingomyelinase (ASM; Grassmé et al., 2001a; Henry et al., 2013). Several 
neutral- and alkaline sphingomyelinases have been identified, defined by the optimal 
pH for respective enzyme activity (Henry et al., 2013; Kornhuber et al., 2015). A 
disruption of the sphingolipid rheostat in the brain can be one pathogenic pathway 
into depression/anxiety. ASM over-expressing mice (tgASM) showed higher ASM 
activity and ceramide production in the hippocampus (Gulbins et al., 2013). 
Increased ceramide levels in the hippocampus resulted in reduced levels of 
neurogenesis, neuronal maturation, and neuronal survival (Gulbins et al., 2013, 
2015), which is normally associated with a depression-like phenotype (Santarelli et 
al., 2003). Consistent with these previous observations, tgASM mice showed a 
depression/anxiety-like phenotype in several tests including the novelty-suppressed-
feeding test, the splash-test, open field, light-dark-box, and forced-swim test (Gulbins 
et al., 2013; Kornhuber et al., 2014; Müller et al., 2015). However, ceramides do not 
directly control synaptic structure or function in the hippocampus (Gulbins et al., 
2013). Antidepressant drugs, many of which appear to be functional inhibitors of 
ASM (Albouz et al., 1986; Kornhuber et al., 2010, 2011), reversed the effects of 
chronic unpredictable stress on behavior in wild type and tgASM animals, but not in 
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ASM KO mice. These findings provide a common stress- as well as genetically 
triggered pathway into a sphingolipid-mediated depression (Gulbins et al., 2013; 
Kornhuber et al., 2014; Grassme et al., 2015; Müller et al., 2015). 
The clinically observed co-morbidity of depression with alcohol addiction appears to 
have two causal pathways. In one pathway, alcohol addiction develops first with a 
depression occurring as induced by the alcohol consumption. This pathway is supported by 
findings showing that alcohol enhances the activity of ASM and results in increased ceramide 
levels in cell cultures (Pascual et al., 2003; Saito et al., 2005), in rodent models (Saito et al., 
2010; Liangpunsakul et al., 2012), and in humans (Reichel et al., 2010, 2011). In another 
pathogenetic pathway, however, the depression manifests first leading to an enhanced 
alcohol consumption and finally addiction (Room, 2000; Schuckit et al., 1997, 2006, 2007, 
2013). In those patients, alcohol was suggested to be used and instrumentalized to 
ameliorate the suffering from depression/anxiety (Müller and Schumann, 2011a, Müller, 
2015). How those seemingly paradoxical effects of the alcohol work in the brain of a 
depressed organism was recently identified. Mice with a hyperfunction of acid 
sphingomyelinase are not only depressive, but consume also significantly more alcohol and 
escalate consumption after withdrawal (Müller et al., 2017). Free-choice alcohol 
consumption in a two-bottle free-access paradigm, but not forced injections of equivalent 
amounts of alcohol, partly reversed the ASM hyperactivity in tgASM mice. Importantly, the 
alcohol self-titration also normalized the depressive symptoms up to the level of WT animals. 
ASM hyperactivity resulted in an attenuation of the most abundant sphingomyelin species in 
the NAc and dorsal hippocampus (DH). Alcohol drinking in WT mice had a similar effect on 
the sphingolipid rheostat. In tgASM mice, however, alcohol drinking had a paradoxical effect 
in that it partially reversed the genetically induced deficit in the NAc, but not in the DH. These 
findings not only suggest a highly brain-region selective control of the sphingolipid rheostat, 
but also locally selective effects of the self-administered alcohol. Depressive tgASM mice 
also showed a gross attenuation of DA- and 5-HT tissue levels in the brain. Alcohol drinking 
almost completely reversed this deficit in the tgASM mice, but had an opposite effect in WT 
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mice (Müller et al., 2017). This study showed in particular that it is not only the 
pharmacological effect of the alcohol that matters, but the possibility for the organism to self-
titrate the consumed amount. It also highlights that a psychoactive drugs can have quite 
distinct effects depending on the mental state of an organism (Müller and Kornhuber, 2017). 
These findings confirm animal models which showed that voluntary alcohol self-
administration may reduce depressive symptoms and by that way sustain high consumption 
rates (Ciccocioppo et al., 1999; Tizabi et al., 2018).  
Posttraumatic stress disorder (PTSD) is associated with an enhanced consumption and 
addiction to psychoactive drugs (Stewart, 1996; Roberts et al., 2015).  Acute severe stress 
causes an enhanced responsiveness to mild stressors at endocrine and behavioral level. It 
enhances the reinforcing action of psychostimulant drugs, alcohol and opiates, and their self-
administration and resistance to extinction acutely, as well as long after the stress has ended 
(Piazza et al., 1989; Pizzimenti et al., 2017; Logrip et al., 2012). In most cases, a PTSD 
emerges first and triggers development of drug abuse and addiction. However, precedent 
drug abuse may also enhance vulnerability to stressful events. The self-medication 
hypothesis that is now well supported by human data suggests that patients consume 
psychoactive drugs to control their PTSD symptoms (Khantzian, 1985, 1997). Alcohol was 
reported to dampen arousal and reduce physiological reactivity to stressors (Stewart, 1996; 
Sher et al., 2005). Thereby, a tension reduction may act as a negative reinforcer and further 
drive alcohol consumption (Conger, 1951). Alcohol may also reduce fear and avoidance 
behavior and intrusive cognitive symptoms, such as distressing recollections of the aversive 
event (Stewart, 1996). Depending on the type of stress used to model PTSD, an increase in 
consumption may not occur immediately, but with some time delay (van Erp and Miczek, 
2001, van Erp et al., 2001). It is now understood how acute severe stress sensitizes the 
reward system for psychoactive drug effects and by that way makes it more vulnerable to 
addiction development (Yap and Miczek, 2008; Manjoch et al., 2016). The mechanisms of 
how the self-administration of psychoactive drugs can revert some of the brain dysfunctions 
induced by PTSD, however, are currently less well understood.     
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 Patients with schizophrenia show an increased consumption of nicotine and 
cannabis (Hughes et al., 1986; Mobascher and Winterer, 2008). While those drugs may 
exacerbate positive symptoms, such as hallucinations (Perry and Perry, 1995), aversive 
negative symptoms, such as the flattening of affect, and cognitive impairments, might be 
improved by nicotine (Rezvani and Levin, 2001; Potvin et al., 2003). It is well known that 
schizophrenic patients consume nicotine and marijuana/cannabis at a level that exceeds 
that of the normal population, frequently resulting in a comorbid drug addiction. Reports from 
patients and experimental investigations suggest that those drugs may ease suffering from 
negative symptoms and, to a certain degree, improve cognitive impairments (Dome et al., 
2010; Newhouse et al., 2011).   
The improvement of cognitive deficits in schizophrenia has been shown in a rat model. 
Schizophrenia-like cognitive deficits in latent inhibition and a delayed non-matching to 
sample test were induced by maternal immune activation (MIA) with lipopolysaccharide 
(LPS) during gestation. MIA did not enhance nicotine self-administration in the offspring. 
Nicotine self-administration ameliorated the MIA-induced cognitive deficits, but had no 
effects in a saline control group (Waterhouse et al., 2018).    
In a recent study, nicotine effectively improved cognitive deficits in a mouse model of 
schizophrenia resembling a human condition. A human genome wide association study in 
schizophrenia patients yielded the rs16969968 single nucleotide polymorphism (SNP) of the 
human CHRNA5 gene as significantly associated. This gene codes for the 5 subunit of the 
nicotinergic ACh receptor (nAChR; Schizophrenia Working Group of the Psychiatric 
Genomics Consortium; 2014). This SNP was associated with enhanced risk for 
schizophrenia as well as tobacco smoking. It leads to a substitution of aspartic acid by 
asparagine at the 398 locus of the human 5 subunit of the nAChR. The functional 
implications of this SNP were subsequently investigated in a mouse model. Transgenic mice 
expressing the human 5 SNP showed deficits in social behavior and in sensumotor gating, 
both typical symptoms of schizophrenia. Disrupted 5 subunit function was associated with 
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a decrease in GABA interneuron-driven prefrontal cortex layer II/III microcircuit activity. This 
effect directly translates to the frontal brain hypoactivity observed in schizophrenia patients. 
Continuous nicotine administration for 2 days via mini pump delivery normalized the firing of 
neurons selectively in 5-deficient mice (Koukouli et al., 2017). These findings suggest that 
nicotine self-administration is particularly effective in ameliorating cortical dysfunction in a 
subpopulation of schizophrenics, those with a polymorphism of the 5 nAChR (Koukouli et 
al., 2017; Müller and Kornhuber, 2017).  
Altogether, several psychoactive drugs were found to be useful by individuals suffering from 
psychiatric disorders to temporarily ameliorate at least some disease symptoms or subjective 
suffering from them. Prolonged and escalating drug use for this goal, however, may 
eventually potentiate disease symptoms and result in a co-morbid addiction disorder 
(Robbins and Everitt, 1999; Müller, 2017). 
2.3.6. Sensory curiosity – expanded perception horizon 
Boredom is a mildly aversive mental state, perceived in the absence of novel sensory 
input. One may readily assume that the search for novelty and new environments is a driving 
force to expose an individual to stimuli and environments where new stimulus–reward 
contingencies exist that can be learned (Kelley et al., 1990; Thiel et al., 1999). Novelty and 
new sensations can be considered as primary reinforcer in humans and animals 
(Zuckerman, 1990; Weil, 1998). Novelty seeking has been shown to be an at-risk phenotype 
for drug abuse with a shared genetic base (Zuckerman, 1990; Mielenz et al., 2018). A 
psychoactive drug-induced mental state change may well constitute a novelty effect, at least 
during the first consumption episodes. Unique subjective drug effects are reflected in the 
discriminative stimulus properties of a drug in humans and animal models (Overton, 1968; 
Stolerman, 1992). After repeated exposure, the drug effects on mental state are not novel 
anymore and other than the rewarding novelty effects are required to maintain drug seeking 
and consumption. If there are no other instrumentalization goals emerging, the consumption 
of this particular drug may cease (Nichols, 2004).  
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A particular group of psychoactive drugs used to change sensation and perception of 
the external world and to increase self-understanding and self-discovery are hallucinogenic 
drugs, including natural compounds, like mescaline and psilocybin, as well as semi-synthetic 
drugs, like lysergic acid diethylamide (LSD) (Cato, 1992; Boys et al., 1999, 2000; Tupper, 
2002, 2003; Boys and Marsden, 2003; Nichols, 2004; Morgan et al., 2013). A similar 
instrumentalization might also apply to the enactogenic drug, MDMA (Boys et al., 1999, 
2000), which has a hallucinogenic profile and induces a unique feeling of ‘divine oneness’ 
with the world (Halberstadt and Nichols, 2010). Phencyclidine, ketamine and -
hydroxybutyrate (GHB) are drugs used in the club and rave scene. At high dose, they can 
have profound hallucinogenic effects (Weir 2000; Britt and McCance-Katz, 2005; Wolff and 
Winstock, 2006; Hassan et al., 2017). Also cannabis was reported to be consumed in order 
to expand self- and environmental perception (Bonn-Miller et al., 2007; Zvolensky et al., 
2007).  
In a dull and familiar environment, with no or very little valuable stimulation, like that in 
a standard operant box, animals may also take drugs as a mean to obtain and experience 
some artificial stimulation. They may also use drugs as a mean to amplify or increase the 
gain of the brain reward circuits to otherwise neutral environmental stimuli (Ahmed and Koob, 
2005; Keramati et al., 2017). Of course, in such impoverished environments, animals have 
also no access to alternative valuable rewards and thus their drug use could also be partly 
motivated by the search of novelty reward. Long-term and escalating drug use for this 
instrumentalization goal may result in dangerous activities and schizophrenia-like psychoses 
(Müller, 2017).      
2.3.7. Euphoria, hedonia, and high 
The pursuit of euphoria or happiness is probably the greatest motivation in human life 
(Tatarkiewicz, 1976; Marcuse, 1984). In humans, this subjective feeling is frequently 
occurring during/after the receipt of a primary or secondary reward, or with the unexpected 
change in reward contingencies, i.e. when a formerly meaningless stimulus now predicts 
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reward availability or a formerly useless behavior. While the biological function of the 
subjective perception of euphoria is still under debate (Berridge, 2000; Alcaro and Panksepp, 
2011), it appears that the amount of euphoria we perceive is related to human well-being. It 
was argued that mood enhancement alone and subsequent facilitation of virtually all kind of 
goal directed behaviors is a psychological benefit gained from psychoactive drug use (Peele 
and Brodsky, 2000; Lende and Smith, 2002). Psychoactive drugs like heroin, morphine, 
cocaine, amphetamine, methamphetamine, methylphenidate, and MDMA in middle to high 
doses can induce a strong feeling of euphoria and an emotional ‘high’ (e.g. Resnick et al., 
1977; Javaid et al., 1978). They are used for this reason by non-addicts (Boyd et al., 2006; 
Teter et al., 2006; McCabe et al., 2007; Zacny and Lichtor, 2008). A certain degree of 
euphoria can also be induced by other drugs of abuse, such as alcohol, cannabis, LSD, 
benzodiazepines, and nicotine (e.g. Boys et al., 1999, 2000; Boys and Marsden, 2003; Sher 
et al., 2005). However, the latter are usually not reported to be primarily consumed for this 
reason. 
Psychoactive drugs were claimed to produce their strong euphoria-inducing effects by 
a massive increase of the extracellular DA activity in the NAc (Di Chiara and Imperato 1989; 
Di Chiara 1995), which is a key structure of the brain’s reward circuitry (Olds and Milner 
1954; Wise 1980, 1994). The mechanisms how the pharmacologically distinct drug classes 
converge on the mesolimbic DA signaling have been elucidated in detail (Koob 1992; Di 
Chiara and North 1992; Volkow et al. 1997; Ameri 1999; McBride et al. 1999). In humans, 
drug-induced euphoria is usually more intense than naturally occurring euphoria. And so is 
the amplitude and slope of the DA increase in the NAc (Müller and Huston, 2007; Samaha 
and Robinson, 2005). However, several conceptual problems emerged with this hypothesis 
(Salamone et al. 1996), thus, leading to a conceptual and anatomical distinction of stimulus 
induced “wanting” and “liking" (Robinson and Berridge, 1993; Berridge and Robinson, 2003). 
According to this view, DA may not code for the euphoria, but rather for “wanting” and signal 
a reward-related prediction error (Hollerman and Schultz 1998; Schultz 2000). This may not 
only apply for pleasant appetitive stimuli, but also for aversive stimuli (Young et al. 1993; 
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Brischoux et al. 2009; Matsumoto and Hikosaka 2009). While DA may still have an 
outstanding role for reinforcement learning, drug use and addiction (Robbins and Everitt 
1996; Ikemoto and Panksepp 1999), it is no longer the principal signal associated with 
euphoria or ‘liking’). Euphoria and the ‘liking’ of a stimulus may, instead, be mediated by 
endogenous opioid- and GABAergic mechanisms (Berridge and Robinson 2003; Berridge 
and Kringelbach, 2015). Besides those two, also other transmitter systems and signaling 
cascades have been identified as modulators of the euphoria-inducing and reinforcing 
effects of psychoactive drugs (Nestler and Aghajanian 1997; Koob 1999; Everitt and Wolf 
2002; Kalivas and Volkow 2005; Williams and Adinoff 2007; Heilig and Koob 2007; Müller 
and Homberg, 2015).  
However, chronic over-instrumentalization of a drug for this instrumentalization goal 
frequently results in tolerance to the euphoria effects and a subsequent escalation of intake, 
which may result in an addiction development (Koob and LeMoal, 1997; Heilig and Koob, 
2007). 
2.3.8. Other instrumentalization goals 
Besides the above discussed instrumentalization goals, there are other behaviors that 
humans report to benefit from psychoactive drugs in a non-addicted consumption. Other 
instrumentalization goals include the ‘Improvement of physical appearance and 
attractiveness’ (Garattini et al. 1978; Goldstein 1990; Boys et al. 1999, 2000; Boys and 
Marsden 2003), the ‘Facilitation of spiritual and religious activities’ (Abel, 1980; Streatfeild, 
2001; Jay, 2010), and the ‘Improvement of physical performance’ (e.g. sport doping) (Müller 
and Schumann, 2011a, 2011b, Müller, 2017). Since they may apply exclusively to humans, 
no animal models have been developed so far. An important motive for drug self-
administration in animals and humans is also to self-medicate for physical problems and its 
indicator, pain (Colpaert et al., 2001). However, to the best of our knowledge there are no 
mechanistic insights available that go beyond pharmacological action of the drugs used for 
those purposes.      
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2.4. Drug seeking and taking depends on behavioral alternatives 
2.4.1. Drugs as goals and instruments 
To take stock, evidence suggests that individuals seek and take drugs not merely or 
even primarily as pharmacological rewards but also as means or instruments to reach other 
valued ends or goals (Müller and Schumann, 2011a; Pickard, 2012; Sullivan and Hagen, 
2002). Beside their rewarding effects, drugs of abuse also produce specific 
psychopharmacological effects, some of which can be instrumentalized to facilitate the 
pursuit and attainment of certain specific goals (Badiani et al., 2011; Khantzian, 1997; Müller 
and Schumann, 2011a). For instance, at low to moderate doses, alcohol can produce 
anxiolytic effects that certain individuals intently seek and use to overcome their anxiety in 
certain social settings to better pursue and attain other pursuits that they value (e.g., 
approach to and interaction with a future potential mate) (de Wit and Sayette, 2018; 
Edwards, 2000). In other words, alcohol would not be a goal in and of itself but a mean to 
reach a different nondrug-related goal. In the real world, these two facets of drug use – which 
are relatively easy to separate in theory – are often entangled, mainly because people tend 
to use drugs both as a mean and as an end (Edwards, 2000; Müller and Schumann, 2011a; 
Zinberg, 1984). This may contribute to explain why the recourse to drugs as instruments has 
been relatively overlooked until recently. Nevertheless, serious consideration of this 
recourse seems to uniquely explain some important aspects of drug use that were previously 
difficult to account for from an exclusive drug reward-centric perspective, such as, for 
instance, the psychopharmacological specificity of drug use discussed above. Indeed, since 
different drugs produce different psychopharmacological effects, the recourse to drug 
instrumentalization is expected to be largely drug-specific, a prediction that is borne out by 
mounting evidence from research on both humans and animals (Badiani, 2013; Badiani et 
al., 2011). 
2.4.2. Behavioral alternatives modulate the recourse to drug instrumentalization 
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 Importantly, the recourse to drug instrumentalization should not only depend on how 
the psychopharmacological effects of a specific drug help an individual to pursue and attain 
certain nondrug-related goals but also on whether other relevant behavioral alternatives to 
attain those same goals are available. Such recourse is thus predicted to be particularly likely 
and/or prevalent in situations or settings that offer no or little behavioral alternatives. This 
may contribute to explain why drug use and substance use disorders tend to be more 
prevalent or endemic in human populations that live in economically and socially 
impoverished environments in which, by definition, access to behavioral alternatives is 
lacking or limited (Alexander, 2008; Hart, 2013; Hartnoll, 1990; Heilig et al., 2016; Orford, 
2013). For instance, though smoking occurs in several different socioeconomic contexts, 
there is nevertheless a pronounced socioeconomic gradient in the prevalence of drug use 
and substance use disorders (Jarvis and Wardle, 2006; Peretti-Watel et al., 2009). Limited 
access to behavioral alternatives may also contribute to explain why abstinence is difficult to 
maintain in the long term as it is frequently interrupted by recurring relapses. It is indeed 
difficult to give up drug use if one has limited access to relevant behavioral substitutes. A 
critical aspect of addiction treatment consists in helping addicts to find meaningful and 
accessible behavioral alternatives to drug use (McKay, 2017; Miller et al., 2011). This aspect 
is even a core principle of some prominent therapies, such as contingency management 
therapy (Dutra et al., 2008; Higgins et al., 1991; Stitzer and Petry, 2006). Consistent with 
this view, when spontaneous recovery occurs, it does when addicts undergo important life 
changes, generally in their late 30s that open up a wide range of new alternative 
opportunities, e.g. a new fulfilling job and/or social relationships (Heyman, 2009; Heyman, 
2013). However, since in underprivileged environments, nondrug reward alternatives are 
also limited, one cannot exclude the possibility that people also seek drugs as 
pharmacological rewards, i.e., drug rewards as goals, and not only or even predominantly 
as means or instruments to achieve other nondrug-related pursuits. At present, it is difficult 
to see how one could tease out apart these different, albeit not mutually exclusive, 
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interpretations. As we will see below, the same difficulty also exists in experimental research 
on animal drug self-administration. 
2.4.3. Behavioral alternatives in animal models of drug addiction 
The lack of access to behavioral alternatives during access to drugs for self-
administration is endemic to mainstream research on laboratory animals since its inception 
in the early 60s (Ahmed, 2005, 2010, 2018). Animals frequently used in this research, such 
as rats, descend from wild social species, but in experimental settings they are typically 
raised and tested in asocial or nonsocial environments that one would consider to be 
extreme – abnormal and even traumatic if applied to a human individual (Heilig et al., 2016). 
For instance, laboratory rats used in addiction research are typically raised and tested in a 
state of relative isolation and/or extreme environmental poverty since weaning. When one 
considers this state of affairs seriously, it becomes plausible that animals, like humans, could 
use drugs not only or even predominantly to seek drug reward, but also as a mean to self-
medicate a negative psychological condition and/or to adjust to an impoverished 
environment (Alexander and Hadaway, 1982; Heilig et al., 2016; Wolffgramm, 1991). This 
has led some researchers to propose that the standard drug self-administration setting may 
represent a good model of impoverished environments that favor drug use in humans 
(Ahmed, 2005; Ahmed and Koob, 2005). This hypothesis seems to be generally consistent 
with research showing that drug taking can be strongly modulated by the availability of 
behavioral alternatives during drug access. This evidence has been reviewed extensively 
elsewhere (Ahmed, 2005, 2010, 2012, 2017) and will only be briefly summarized below. 
However, it is important to note at the outset that this evidence is currently only suggestive 
and does not provide yet unequivocal support for drug instrumentalization in laboratory 
animals. This is mainly because, apart perhaps from some drug self-medication studies, 
involving the use of non-addictive substances (de Roode et al., 2013; Huffman, 2003; 
Shurkin, 2014), there is just an emerging formal demonstration that animals could use drugs 
as pharmacological instruments to pursue and attain other nondrug-related goals. Such a 
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demonstration requires methodological approaches able to distinguish in animals between 
drug use as a goal and drug use as a mean or instrument. This is not entirely surprising, 
however, as it is generally difficult to disentangle goals versus means in behavioral research 
on animals (Allison, 1993; Staddon, 1979; Timberlake and Allison, 1974). 
Nevertheless, there is some suggestive evidence, mainly from experimental research 
on animals that adapt drug use as a function of the current situation and/or internal 
physiological state. For instance, there is evidence that rats take more cocaine when hungry 
and in a context where food is absent (Carroll et al., 1979). This increase in drug intake could 
reflect, at least partly, an attempt by rats to instrumentalize the powerful anorexigenic effects 
of cocaine to suppress or reduce hunger when no other behavioral alternative is available. 
However, this interpretation should be tempered by the fact that hungry rats do also take 
more opiates which are known to have orexigenic effects (Carroll et al., 1981).  
The access to behavioral alternatives during drug access could reduce drug use by 
reducing the need to recourse to drug instrumentalization. By far, the most used behavioral 
alternative in experimental research on animals is a behavior or response that is reinforced 
by a palatable food reward, typically sucrose or saccharin (Ahmed, 2005, 2010, 2012, 2017; 
Ahmed et al., 2013). In a typical experiment, animals have thus the choice between taking a 
drug and engaging in an alternative course of action aimed at obtaining and consuming a 
food reward. This food alternative-centric design may reduce the generalizability of this 
research. However, recent unpublished research in rats indicates that similar findings can 
also be obtained with other behavioral alternatives, such as positive social interaction (Marco 
Venniro and Yavin Shaham, personal communication).  
The influence of a behavioral alternative on drug use is not absolute, but largely depends on 
the prevailing choice setting (Ahmed, 2017). For instance, access to a palatable food reward 
during access to i.v. heroin for self-administration decreases heroin use only when the effort 
required to obtain the drug is relatively important (Lenoir and Ahmed, 2008) or when the 
choice between the two rewards is mutually exclusive (Fig. 11) (Ahmed, 2017). For instance, 
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when rats must choose either saccharin or heroin, the large majority opts for the nondrug 
alternative, even when relatively high doses of heroin are available for choice (Lenoir et al., 
2013; Madsen and Ahmed, 2015; Secci et al., 2016; Tunstall et al., 2014; Vandaele et al., 
2016). In some experiments, all rats stop to use heroin entirely in favor of the behavioral 
alternative and this abstinence persists during several weeks (Venniro et al., 2017b). Similar 
results have also been found when the drug available for exclusive choice was cocaine 
(Augier et al., 2012; Cantin et al., 2010; Guillem and Ahmed, 2017; Kearns et al., 2016; 
Kerstetter et al., 2012; Lenoir et al., 2007; Madsen and Ahmed, 2015; Perry et al., 2013; 
Tunstall and Kearns, 2013, 2016; Tunstall et al., 2014; Vandaele et al., 2016), 
methamphetamine (Caprioli et al., 2015a; Caprioli et al., 2017; Caprioli et al., 2015b; Venniro 
et al., 2017a) or nicotine (Huynh et al., 2017; Panlilio et al., 2015). This spontaneous 
abstinence behavior can be interpreted as an animal model of contingency management 
therapy for addiction treatment (Ahmed, 2010; Venniro et al., 2017a). Briefly, in contingency 
management, addicts also face a mutually exclusive choice between drug use and a nondrug 
behavioral alternative, typically a voucher that can be used subsequently to purchase 
nondrug commodities (Higgins et al., 1991). Recent research on animals has shown that 
relapse after cessation of contingency management involves activation of a glutamatergic 
pathway that links the anterior insular cortex to the central amygdala pathway (Venniro et 
al., 2017a). 
This research demonstrates that introducing behavioral alternatives during drug access 
can lead under some circumstances to reduced drug intake and even precipitate long-term 
abstinence. However, the behavioral interpretation of this observation remains largely 
uncertain. In particular, we do not know if animals stop using drugs because behavioral 
alternatives represent alternative means that reduce the need to recourse to drug 
instrumentalization, or merely because they represent competing reward goals. The crux of 
the problem is that we lack valid models of drug instrumentalization in animals. When an 
animal takes a specific drug in a particular context or setting, it is difficult to know if it seeks 
to exploit some of the resulting drug effects as a mean or instrument to pursue and attain 
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other nondrug-related goals, which are often unspecified or unknown and/or if it pursues the 
drug rewarding effects as a goal in and of itself. This is further compounded by the fact that 
in a typical drug self-administration study, we ignore what are the specific nondrug-related 
goals that animals are hypothesized to pursue, if any. 
3. Summary and Outlook 
Non-pharmacological factors in psychoactive drug abuse and addiction have been 
recognized for some time. How they act at neurobiological level is now emerging for some 
of them. Thereby, they may still appear as independent factors mediated by largely distinct 
brain mechanisms. However, in human reality of a drug consumer they act together. Related 
to the reviewed progress, drug taking can be considered as a drug, acting on an individual 
that is submitted to a social environment, to stress, but having opportunities to choose 
between drugs and even instrumentalize them to improve efficacy of other behaviors. There 
are also behavioral alternatives to drug consumption. All these factors, and presumably 
some more, ultimately shape the behavioral repertoire of an individual in which drug seeking 
and taking is initially just one among many expressed behaviors. Under specific 
multifactorial, actively chosen and passively incurred environmental conditions (Müller et al., 
2012), the behavioral repertoire may change. In that, drug related behaviors increase, and 
alternatives drop in their likelihood. In this respect the discussed mechanisms converge and 
may, each on its own right contribute to such a development. On the other hand they also 
offer ways of prevention and strategies for addiction treatment.   
While the pharmacological effects of psychoactive drugs are increasingly understood 
and neurochemical alterations during addiction development identified, it remains to be 
acknowledged that this is still insufficient for a satisfactory understanding of drug abuse and 
addiction. Current neuropharmacological models fail at several crucial points. First, they 
frequently do not incorporate essential observations on human drug abuse and addiction 
(Hall et al., 2015; Badiani et al., 2018; Müller, 2018). They are still too much restricted to one 
or few systems in their causal accounts. And, the mechanisms of controlled drug use, which 
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is for many drugs an acceptable behavior (Heath, 2000; Müller and Schumann, 2011a, 
2011b), are frequently conceived as identical with those of addiction, which is clearly 
pathologic. As such no overarching system’s concept of controlled drug use and addiction is 
currently available. Second, the predictions that the available neuropharmacological models 
make for addiction prevention and treatment are relatively poor. Hardly any of the 
pharmacotherapies derived from those models work to an extend that allows us to claim 
them as theory based rational treatment (McCreary et al., 2015; Müller, 2018). While the 
findings reviewed above seriously question the common models that focus mainly on the 
pharmacological drug action in the brain, they also provide a perspective for future research 
strategies and envision alternative addiction prevention and treatment approaches.  
Thereby, a driving force may be the increasingly emerging insights into the neurobiology of 
non-pharmacological mechanisms of drug abuse and addiction. This should have 
implications on how drug use and addiction might be conceptualized in the future. Neither 
controlled drug use nor addiction can be understood as the consequence of dysregulations 
in a single brain target or transmission system. Nor can single functional pathways or 
systems in the brain, like the reward system, fully account for highly individual and complex 
drug action and long term effects. An expanded system’s approach needs to address 
multiple dimensions. Thereby, the “system” should be no longer a pathway in the brain, the 
brain, or even the brain with a sourrounding organism, but expanded to the environment and 
the virtually always present interaction with it. It may even be necessary and useful to 
systematically develop our understanding of the “environment” concept as passively incurred 
versus actively chosen and shaped (Laland et al., 2000; Müller et al., 2012). In fact, there is 
no drug effect on the brain alone, no effect on the organism alone, but always on the 
organism in a particular environment with active as well as passive interactions (Müller et 
al., 2012). Likewise do all drug-related behaviors, from searching to consumption, take place 
in an environment that may or may not be shaped and searched out by the drug user (Laland 
et al., 2000).   
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Active as well as passive environmental interactions of the drug consuming individual receive 
now a peripheral physiological as well as neurophysiological base in our understanding, 
which emerges as a strong determinant of the pharmacological drug effects. An expanded 
system’s understanding of drug abuse and addiction should, therefore, incorporate mental 
states (sets), passive environmental conditions (settings), active environmental conditions 
(stress responses and behavioral alternatives) as well as the manifold drug 
instrumentalization opportunities. Individualized treatment approaches of drug addiction may 
also benefit from recognizing the disorder as a multi-causal and multi-dimensional 
development.      
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Figure legends 
Figure 1. Drug preferences in rats that were trained to self-administer heroin and cocaine 
either at home or outside the home on alternate days and were then given the opportunity 
to choose between the two drugs within the same session, for several daily sessions (see 
text for details). At home, most rats exhibited a preference for heroin over cocaine. Outside 
the home, most rats tended to prefer cocaine to heroin. Some rats did not exhibit significant 
drug preferences; data from: Caprioli et al. (2009). Both the Mann-Whitney test and the 
Fisher exact probability test indicated significant differences in preference (p≤0.05). 
Figure 2. Setting preferences for heroin versus cocaine use in individuals with substance 
use disorder in studies using a within-subject design. Most of these individuals reported 
using heroin exclusively or prevalently at home. In contrast, the same individuals reported 
using cocaine exclusively or prevalently outside the home. Similar results were obtained in 
addicts using the intravenous route or the intranasal route for both drugs. Some addicts did 
not report clear setting preferences. Data from: Caprioli et al. (2009) and Badiani and 
Spagnolo, (2013). The McNemar's test indicated a significant within-subject shift in the 
setting for cocaine vs. heroin taking (p < 0.0001). 
Figure 3. The setting of drug taking affects in opposite directions the intake of drugs that 
depress the central nervous system (CNS), such as opioid agonists and alcohol, versus drug 
that have a stimulant effects on the CNS, such as cocaine, amphetamine, and ketamine 
(data from: Caprioli et al. (2007, 2008), Testa et al. (2011), and De Luca and Badiani (2011)). 
Figure 4.  Peri-infusion 50-kHz USVs in the 10 s before and 40 s after each of the ten 
consecutive self-administered infusions for rats trained to self-administer heroin and cocaine 
on alternate days, either at home or outside the home.  Data were collected on sessions 13 
and 14 and were expressed as delta score relative to saline self-administration sessions 
(sessions 15 and 16); for details see: Avvisati et al. (2016). 
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Figure 5. Increase in lever pressing (means  SEM) during a reinstatement session in rats 
that were trained to self-administer heroin and cocaine on alternate days, either at home or 
outside the home, and then underwent an extinction procedure. At the beginning of the 
reinstatement session, independent groups of rats received non-contingent intravenous 
infusions of one of three doses of cocaine or heroin. At home, rats relapsed into heroin 
seeking but not into cocaine seeking. Outside the home, the rats relapsed into cocaine 
seeking but not into heroin seeking. Data were expressed as change in lever pressing 
relative to the last extinction session.  * and *** indicate a main effect of priming (p≤0.01 and 
p≤0.0001, respectively); for details see: Montanari et al. (2016)  
Figure 6. Total number of intravenous cocaine infusions self-administered during a 24 h 
unrestricted-access binge by rats exposed to 10 d of episodic stress (n = 14; light gray bars) 
and corresponding controls (n = 14; open bars) or exposed to 36 d of continuous social 
stress (n = 9; dark gray bars) and corresponding controls (n = 8; open bars). All values are 
means ± SEM; #p < 0.05, ##p < 0.01, compared with the relevant control group (data from: 
Miczek et al. (2011)). 
Figure 7. Effects of episodic social defeat stress on total IV infusions self-administered in an 
unlimited access cocaine “binge” (0.3 mg/kg/infusion, FR1) in male (control n=8, stressed 
n=8) and female (control n=12, stressed n=10) rats. Self-administration terminated after 120 
minutes without a cocaine infusion. Values are means ± SEM; #p<0.05, ##p<0.01 vs same-
sex control (data from: Holly et al. (2012)). 
Figure 8. 20% ethanol intake (g/kg/day) during continuous access 2-bottle choice over the 
course of 20 days, starting 10 days after moderate (n=39) or mild (n=19) social defeat stress 
(control, n=29). Data points are 5-day averages ± SEM beginning on the day indicated (i.e. 
25 signifies days 25- 29); **p<0.001 vs. controls (adapted from: Norman et al. (2015)). 
Figure 9. Dopamine levels (pmol/15 μl) in the nucleus accumbens. White circles are mice 
with continuous ethanol (EtOH) access (CA; n = 7), gray triangles are mice with intermittent 
EtOH access (IA; n = 7), and black squares are socially defeated mice with intermittent EtOH 
access (Str+IA; n = 7). Arrows denote intra-VTA microinjections of aCSF and 0.6 μg 
CP376395. Values are means ± SEM, *p < 0.05 vs. CA, #p < 0.05 vs. baseline. The bars 
show area under the curve (AUC) after the CP376395 microinjection (data from: Hwa et al. 
(2016)). 
Figure 10. Role of VTA CRF during stress on later cocaine self-administration. Top: 
Stressed rats pretreated with aCSF before each social defeat (dark gray, n = 11) self-
administered significantly more cocaine during a 24 h “binge” compared with aCSF-
pretreated nonstressed controls (white, n = 13). This was prevented with intra-pVTA 
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antagonism of CRF-R1 (light gray, CP, n = 4), but not intra-aVTA CRF-R1 antagonism 
(medium gray, CP, n = 4). Cumulative infusions in 2 h bins are shown on the left, with total 
infusions shown on the right. Bottom: Conversely, intra-aVTA CRF-R2 antagonism (medium 
gray, A2B, n = 4), but not intra-pVTA CRF-R2 antagonism (light gray, A2B, n = 5), prevented 
stress escalation of cocaine self-administration during the 24 h binge. **p < 0.01 vs. aCSF-
nonstressed, ###p < 0.001 vs. aCSF-stressed (data from: Holly et al. (2016)). 
Figure 11. Choice between heroin and a nondrug alternative. (a) Top view of an operant 
chamber showing a rat choosing between a heroin-paired lever and a sweet water-paired 
lever. (b) Mean preference scores (± SEM) as a function of testing sessions. The horizontal 
dashed line at 0 represents the indifference level. Values above 0 indicate a preference for 
water sweetened with saccharin while values below 0 indicate a preference for intravenous 
heroin. (c) Mean preference scores as a function of i.v. heroin doses. *, different from the 
indifference level (p< 0.05, t-test) (adapted from: Lenoir et al. (2013)). 
Table 1. Substance-specific effects of setting on the rewarding effects of heroin versus 
cocaine in the rat. 
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Table. 1 
  Heroin Cocaine 
Intake 
Caprioli et al. 2007, 2008, 2009 
Celentano et al. 2009 
 Rats take more heroin at home 
than outside the home 
Rats take more cocaine outside 
the home than at home 
‘Motivation’ (PR) 
Caprioli et al. 2007, 2008 
Celentano et al. 2009 
 Rats are willing to work harder 
for heroin at home than outside 
the home 
Rats are willing to work harder 
for cocaine outside the home 
than at home 
Choice: Heroin vs. Cocaine 
Caprioli et al. 2009 
 Residents tend to choose heroin 
at home 
Rats tend to choose cocaine 
outside the home 
‘Pleasure’ (50 kHz USVs) 
Avvisati et al. 2016 
 Heroin ‘pleasure’ is greater at 
home than outside the home 
Cocaine ‘pleasure’ is greater 
outside the home than at home 
‘Craving’ after abstinence 
(Relapse) 
Montanari et al. 2015 
 Rats relapse into heroin seeking 
at home but not outside the home 
Rats relapse into cocaine 
seeking outside the home but 
not at home 
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